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1 General experimental 
All chromatographic separations1 were performed on Silica, 10-18, 60 Å, ICN Biomedicals. Standard 
techniques were used for the purification of reagents and solvents.2 NMR spectra were recorded on a 
Varian Gemini 200 (1H NMR at 200 MHz, 13C NMR at 50 MHz), and on Bruker Avance III 500 (1H NMR at 
500 MHz, 13C NMR at 125 MHz), in deuterated chloroform if not otherwise stated. Chemical shifts are 
expressed in ppm (δ) using tetramethylsilane as internal standard, coupling constants (J) are in Hz. IR 
spectra were recorded on a Nicolet 6700 FT instrument, and are expressed in cm-1. Mass spectra were 
obtained on Agilent technologies 6210 TOF LC/MS instrument (LC: series 1200) or LTQ Orbitrap XL 
hybrid FTMS (Thermo Scientific). Microanalyses were performed at the Vario EL III instrument CHNOS 
Elementar Analyzer, Elementar Analysensysteme GmbH, Hanau-Germany. Optical rotation was 
measured on Rudolph Research Analytical AUTOPOL IV Automatic Polarimeter. Melting points were 
determined on a Kofler hot-stage apparatus and are uncorrected. 
X-ray crystal structure determination 
A single colorless crystal was selected and glued on glass fiber. Diffraction data were collected on an 
Oxford Diffraction KM4 four-circle goniometer equipped with Sapphire CCD detector. The crystal to 
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detector distance was 45.0 mm and a graphite monochromated MoKα (λ = 0.71073 Å) X-radiation was 
employed in the measurements. The frame widths of 1° in ω, with 19 and 27 s were used to acquire 
each frame. More than a hemisphere of three-dimensional data was collected in all measurements. The 
data were reduced using the Oxford Diffraction program CrysAlisPro. A semiempirical absorption-
correction based upon the intensities of equivalent reflections was applied, and the data were corrected 
for Lorentz, polarization, and background effects. Scattering curves for neutral atoms, together with 
anomalous-dispersion corrections, were taken from International Tablesfor X-ray Crystallography.3 The 
structures were solved by direct methods,4 and the figures were drawn using MERCURY.5 Refinements 
were based on F2 values and done by full-matrix least-squares6 with all non-H atoms anisotropic. The 
positions of all non H-atoms were located by direct methods. The positions of hydrogen atoms were 
found from the inspection of the difference Fourier maps. The final refinement included atomic 
positional and displacement parameters for all non-H atoms. The non-H atoms were refined 
anisotropically. However, at the final stage of the refinement, H atoms belonging to molecules were 
positioned geometrically (O−H = 0.82 and C−H = 0.93-0.97 Å) and refined using a riding model with fixed 
isotropic displacement parameters. 
 
 
 
2 Experimental procedures 
 
2.1 (R)-2,6-dimethylhept-5-enal ((R)-norcitronellal) (5)7 
 
Aqueous solution of sodium periodate (4.35 g of NaIO4 in 50 mL of distilled water; 20.3 mol; 3.5 eq) was 
added dropwise to the methanolic solution of (2S,3R)‐3,7‐dimethyloct‐6‐en‐1,2‐diol (1 g of the diol in 45 
mL of methanol; 5.8 mmol). The resulting milky white suspension was stirred at room temperature for 
30 minutes, before it was partitioned between dichloromethane and water. The aqueous layer was 
extracted with dichloromethane (3 x 40 mL) and the combined organic extract was dried over MgSO4. 
The extract was concentrated under reduced pressure (300 mmHg, 25 °C), the residue filtered through a 
short pad of silica, and eluted with dichloromethane. Removal of solvent at rotovap afforded 660 mg 
(80%) of (R)‐2,6‐dimethylhept‐5‐enal 5, as a colorless liquid with a pleasant odor. 
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Spectral data identical to those reported in the literature.8 
 
2.2 (S)-4-benzyl-3-((2S,3R,4R)-2-(benzyloxy)-3-hydroxy-4,8-dimethylnon-7-
enoyl)oxazolidin-2-one (8) 
 
Triethylamine (6 mL; 43 mmol; 1.40 eq) was added to a cold (‐78 °C) solution of (S)‐4‐benzyl‐3‐(2‐ 
(benzyloxy)acetyl)‐oxazolidin‐2‐one 7 (10.34 g; 31.8 mmol; 1.04 eq) in dry dichloromethane (130 mL), 
under an argon atmosphere, followed by a dropwise addition (10 min) of di‐n-butylboron 
trifluoromethanesulfonate (9.3 mL; 37 mmol; 1.2 eq). The mixture was allowed to reach 0 °C during one 
hour, stirred continuously for 15 minutes, and then cooled again to ‐78 °C. A solution of (R)‐
norcitronellal 5 (4.3 g; 30.7 mmol; 1 eq) in dry dichloromethane (20 mL) was added dropwise into the 
reaction mixture, and stirring was continued for 10 minutes at ‐78 °C. The mixture was allowed to reach 
0 °C during 1.5 h and stirring continued for 4 h at that temperature. After cooling to ‐25 °C, the reaction 
was carefully quenched by simultaneous addition of phosphate buffer (140 mL) and methanol (400 mL), 
keeping the temperature below ‐15 °C. A mixture of methanol and 30% hydrogen peroxide (2:1; 280 mL) 
was then added while maintaining the same temperature, and stirring continued for 1 h at 0 °C. The 
reaction mixture was extracted with dichloromethane (3x300 mL), the organic layer was washed with 
brine, dried over MgSO4 and concentrated under reduced pressure. Purification of the crude product by 
MPL chromatography (eluent: toluene : ethyl acetate = 5 : 1) afforded 10.92 g (77%) of aldol 8, as a very 
viscous, colorless oil, which was preceded by unreacted starting oxazolidinone 7 (1.84 g). The yield 
based on the recovered starting oxazolidinone was 90%. 
 
1H NMR (500 MHz, CDCl3)7.19-7.49 (m, 10H), 5.33 (d, J=1.7, 1H), 5.06-5.15 (m, 1H), 4.78 (d, J=11.4, 
1H), 4.66-4.76 (m, 1H), 4.48 (d, J=11.4, 1H), 4.19-4.32 (m, 2H), 3.56 (dt, J1=1.7, J2=10.3, 1H), 3.36 (dd, 
J1=3.3, J2=13.3, 1H), 2.83 (dd, J1=9.6, J2=13.3, 1H), 2.03-2.16 (m, 2H), 1.86-2.00 (m, 1H), 1.71-1.85 (m, 
2H), 1.69 (s, 3H), 1.62 (s, 3H), 1.11-1.25 (m, 1H), 0.90 (d, J=6.7, 3H). 
13C NMR (125 MHz, CDCl3) 171.2, 153.3, 137.1, 135.1, 131.3, 129.4, 129.0, 128.5, 128.46, 128.2, 127.5, 
124.7, 78.2, 76.6, 72.8, 67.1, 55.8, 37.8, 36.3, 32.7, 25.7, 25.2, 17.7, 15.2. 
IR (film): cm-1 3507, 2918, 1777, 1708, 1386, 1210, 1110, 698. 
HRMS (m/z) [M+Na]+ calcd. for C28H35NO5Na: 488.2413; found: 488.2390. 
[]D
20 +20.5 (c 0.8, CHCl3). 
Rf=0.27 (toluene : ethyl acetate = 5 : 1). 
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2.3 (4R,5R)‐5‐(benzyloxy)‐2,2‐dimethyl‐4‐((R)‐6‐methylhept‐5‐en‐2‐yl)‐1,3‐dioxane (9) 
 
A) Compound 75 (Reductive elimination of the oxazolidinone chiral auxillary with sodium borhydride): 
Sodium borohydride (15 mg; 0.4 mmol; 5 eq) was added to a solution of aldol 8 (37 mg; 0.08 mmol) in 
tetrahydrofuran/water  mixture  (5:2;  1.4  mL)  and  the  mixture  was  stirred  75  minutes  at  room 
temperature, before  the excess of  the  reducing agent was destroyed by careful addition of  saturated 
ammonium  chloride  solution  (2  mL).  The  mixture  was  extracted  with  ethyl  acetate  (2x20  mL),  the 
organic  layer was rinsed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
crude mixture of the diol 75 and oxazolidinone was used in next step without  purification. 
 
1H NMR (500 MHz, CDCl3) δ 7.31‐7.39 (m, 5H), 5.10 (t, J=2.8, 1H), 4.74 (d, J=11.5, 1H), 4.60 (d, J=11.5, 
1H), 3.91 (dd, J1=4.5, J2=12, 1H), 3.72 (dd, J1=4.5, J2=12, 1H), 3.57 (dd, J1=4.5, J2=8, 1H), 3.42‐3.44 (m, 1H), 
2.20‐2.35  (bs, 2H), 2.05‐2.18  (m, 1H), 1.89‐1.96  (m, 1H), 1.67‐1.73  (m, 1H), 1.69  (s, 3H), 1.58‐1.64  (m, 
1H), 1.61 (s, 3H), 1.18‐1.24 (m, 1H), 0.89 (d, J=7, 3H). 
13C NMR (125 MHz, CDCl3) δ 138.0, 131.5, 128.6, 128.0, 127.9, 124.6, 78.5, 76.8, 72.5, 62.6, 35.2, 31.7, 
25.7, 25.3, 17.7, 16.1. 
IR (film): cm‐1 3399, 2964, 2921, 2879, 1454, 1054. 
HRMS (m/z) [M+Na]+ calcd. for C18H28O3Na: 315.1931; found: 315.1925. 
[α]D20 +3.6 (c 0.3, CHCl3). 
Rf=0.26 (petroleum ether : ethyl acetate = 2 : 1). 
 
B) Compound 9: The crude mixture of diol 75 and the oxazolidinone obtained in the previous step, was 
redissolved  in  2,2‐dimethoxypropane  (0.8  mL),  pTsOH  (one  crystal)  was  added  and  stirring  was 
continued  for 1 h at  room  temperature. The  reaction mixture was diluted with dichloromethane  (25 
mL), washed with saturated sodium bicarbonate and brine. The organic layer was dried over MgSO4 and 
concentrated under  reduced pressure. Purification of  the crude product by dry‐flash chromatography 
(eluent: petroleum ether : ethyl acetate = 3 : 1) afforded 17 mg (64%) of compound 9, as a colorless oil. 
 
1H NMR  (500 MHz, CDCl3) δ 7.24‐7.38  (m, 5H), 5.10‐5.14  (m, 1H), 4.76  (d,  J=12, 1H), 
4.46  (d,  J=12, 1H), 4.09  (dd,  J1=2,  J2=12.5, 1H), 3.85  (dd,  J1=2,  J2=12=3, 1H), 3.42  (dd, 
J1=1.5, J2=9.5, 1H), 3.26 (dd, J1=2, J2=4, 1H), 1.86‐2.06 (m, 3H), 1.68 (s, 3H), 1.63‐1.71 
(m, 1H), 1.60 (s, 3H), 1.44 (s, 3H), 1.41 (s, 3H), 1.04‐1.11 (m, 1H), 0.71 (d, J=7, 3H). 
13C NMR (50 MHz, CDCl3) δ 138.2, 130.9, 128.3, 128.1, 127.7, 125.1, 98.7, 75.6, 70.6, 69.7, 61.5, 32.4, 
32.3, 29.1, 25.7, 24.8, 18.9, 17.5, 14.3. 
 
O
O
BnO R
H
Me
Me
H
H
H
NOE
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IR (film): cm-1 2965, 2924, 2858, 1377, 1200, 1090. 
HRMS (m/z) [M+Na]+ calcd. for C21H32O3Na: 355.2249; found: 355.2254. 
[]D
20 -14.3 (c 0.3, CHCl3). 
Rf=0.41 (petroleum ether : ethyl acetate = 7 : 1). 
 
2.4 (S)-4-benzyl-3-((2S,3R,4R)-2-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-4,8-
dimethylnon-7-enoyl)oxazolidin-2-one (10) 
 
Freshly distilled sym‐collidine (6.4 mL; 48.3 mmol; 2.5 eq) was added to a cold (0 °C) solution of (S)‐4‐
benzyl‐3‐((2S,3R,4R)‐2‐(benzyloxy)‐3‐hydroxy‐4,8‐dimethylnon‐7‐enoyl)oxazolidin‐2‐one 8 (9.0 g; 19.33 
mmol) in dry dichloromethane (32 mL), under an argon atmosphere. tert‐Butyldimethylsilyl 
trifluoromethanesulfonate (6.7 mL; 29 mmol; 1.5 eq) was then added dropwise and the reaction mixture 
was stirred at room temperature for 15 minutes. The reaction was quenched with saturated sodium 
bicarbonate solution and extracted with dichloromethane. The organic layer was dried over MgSO4 and 
concentrated under reduced pressure. Purification of the crude product by dry‐flash chromatography 
(eluent: petroleum ether : ethyl acetate = 7 : 3) afforded 11.02 g (99%) of compound 10, as a colorless, 
viscous oil. 
 
1H NMR (200 MHz, CDCl3) 7.16-7.45 (m, 10H), 5.32 (d, J=5.4, 1H), 5.05 (t, J=7.1, 1H), 4.66 (ABq, J=3.2, 
2H), 4.44-4.58 (m, 1H), 4.06-4.18 (m, 2H), 3.99 (dd, J1=3.6, J2=5.4, 1H), 3.16 (dd, J1=3.0, J2=13.5, 1H), 2.50 
(dd, J1=10.3, J2=13.5, 1H), 1.73-2.18 (m, 2H), 1.66 (s, 3H), 1.60 (s, 3H), 1.40-1.58 (m, 2H), 1.06-1.26 (m, 
1H), 1.00 (d, J=6.7, 3H), 0.92 (s, 9H), 0.08 (s, 3H), 0.03 (s, 3H). 
13C NMR (50 MHz, CDCl3) 171.8, 152.8, 137.9, 135.3, 131.3, 129.4, 129.0, 128.4, 128.2, 127.8, 127.3, 
124.5, 79.6, 77.5, 73.3, 66.3, 55.9, 37.3, 36.2, 31.3, 26.0, 25.9, 25.7, 18.3, 17.6, 16.6, -4.2, -4.5. 
IR (film): cm-1 2958, 2930, 1784, 1706, 1384, 1210, 1110. 
Elemental analysis: calcd. for C34H49NO5Si: C 70.43%, H 8.52%, N 2.42%; found: C 70.79%, H 8.67%, N 
2.45%. 
[]D
20 +50.3 (c 1.1, EtOAc). 
Rf=0.65 (petroleum ether : ethyl acetate = 3 : 1). 
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2.5  (2R,3R,4R)-2-(benzyloxy)-3-(tert-butyldimethylsilyloxy)-4,8-dimethylnon-7-en-1-ol (11) 
 
A solution of sodium borohydride (1.63 g; 43.1 mmol; 4.2 eq) in distilled water (21 mL) was added 
dropwise into a cold (0 °C) solution of (S)‐4‐benzyl‐3‐((2S,3R,4R)‐2‐(benzyloxy)‐3‐(tert-
butyldimethylsilyloxy)‐4,8‐dimethylnon‐7‐enoyl)oxazolidin‐2‐one 10 (5.94 g; 10.24 mmol) in 
tetrahydrofuran (115 mL). The reaction mixture was stirred at room temperature for 20 h and the excess 
of borohydride was decomposed by slow addition of saturated ammonium chloride solution. 
Tetrahydrofuran was removed under reduced pressure, and the reaction mixture partitioned between 
ethyl acetate (400 mL) and water (100 mL). The aqueous layer was additionally extracted with ethyl 
acetate (3x 100 mL), combined organic solution was washed with brine, dried over MgSO4 and 
concentrated at rotovap. Purification by dry‐flash chromatography (eluent: petroleum ether : ethyl 
acetate = 9 : 1) afforded 3.59 g (86%) of the title compound 11, as a colorless, viscous oil. 
 
1H NMR (500 MHz, CDCl3) 7.25-7.38 (m, 5H), 5.08 (t, J=7.2, 1H), 4.69 (d, J=12.1, 1H), 4.56 (d, J=12.1, 
1H), 3.77 (ddd, J1=4.2, J2=6.4, J3=11.5, 1H),3.66 (dd, J1=4.7, J2=5.6, 1H), 3.62 (dd, J1=5.8, J2=11.5, 1H), 3.53 
(ddd, J1=4.2, J2=5.6, J3=9.8, 1H),1.98-2.10 (m, 2H), 1.84-1.93 (m, 1H), 1.68 (s, 3H), 1.63-1.70 (m, 1H), 1.60 
(s, 3H), 1.44-1.53 (m, 1H), 1.10-1.20 (m, 1H), 0.99 (d, J=6.9, 3H), 0.90 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H). 
13C NMR (125 MHz, CDCl3) 138.6, 131.4, 128.4, 127.7, 127.6, 124.7, 82.4, 76.1, 72.6, 61.7, 35.1, 32.0, 
26.0, 25.7, 25.6, 18.2, 17.6, 17.0, -4.1, -4.5. 
IR (film): cm-1 3459, 2957, 2930, 2858, 1464, 1253, 1085, 1043, 838, 776. 
Elemental analysis: calcd. for C24H42O3Si: C 70.88%, H 10.41%; found: C 71.03%, H 10.16%. 
[]D
20 +8.5 (c 0.9, EtOAc). 
Rf=0.30 (toluene : ethyl acetate = 94 : 6). 
 
2.6 (4R,5R,6R,E)-ethyl-4-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-6,10-dimethylundeca-
2,9-dienoate (12) 
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Dess‐Martin's periodinane (5.5 g; 12.97 mmol; 1.5 eq) was added to a solution of (2R,3R,4R)‐2‐ 
(benzyloxy)‐3‐(tert‐butyldimethylsilyloxy)‐4,8‐dimethylnon‐7‐en‐1‐ol 11 (3.59 g; 8.83 mmol) in dry 
dichloromethane (110 mL) and the mixture was stirred at room temperature for 2.5 h. Solid 
(ethoxycarbonylmethylene)triphenylphosphorane (9.23 g; 26.5 mmol; 3 eq) was added and stirring was 
continued for additional 20 h. The reaction mixture was concentrated under reduced pressure and 
triturated with petroleum ether. The clear solution was decanted from the sticky solid, and dissolved in 
a minimal amount of dichloromethane. Triphenyphosphine oxide was separated again by the addition of 
petroleum ether, the obtained clear extract was combined with the first extract and the trituration 
process repeated two more times. The organic solution was successively washed with 10% sodium 
thiosulfate, saturated sodium bicarbonate and brine, dried over MgSO4 and concentrated under reduced 
pressure. Purification by dry‐flash chromatography (eluent: petroleum ether : toluene = 2 : 1) afforded 
3.45 g (82 %) of (4R,5R,6R,E)‐ethyl‐4‐(benzyloxy)‐5‐(tert‐butyldimethylsilyloxy)‐6,10‐dimethylundeca‐ 
2,9‐dienoate 12, as a colorless oil. 
 
1H NMR (200 MHz, CDCl3) 7.18-7.41 (m, 5H), 6.91 (dd, J1=6.4, J2=15.8, 1H), 6.06 (dd, J1=1.2, J2=15.8, 
1H), 5.05 (t, J=6.7, 1H), 4.58 (d, J=11.8, 1H), 4.39 (d, J=11.8, 1H), 4.22 (q, J=7.1, 2H), 3.97 (dt, J1=1.2, 
J2=6.3, 1H), 3.59 (dd, J1=3.5, J2=6.3, 1H), 1.73-2.14 (m, 2H), 1.68 (s, 3H), 1.59 (s, 3H), 1.31 (t, J=7.1, 3H), 
1.03-1.68 (m, 3H), 0.95 (d, J=6.8, 3H), 0.88 (s, 9H), 0.03 (s, 3H), -0.04 (s, 3H). 
13C NMR (50 MHz, CDCl3) 166.1, 145.5, 138.1, 131.4, 128.2, 127.6, 127.5, 124.7, 122.8, 81.7, 78.6, 71.2, 
60.4, 35.2, 31.0, 26.0, 25.6, 25.5, 18.3, 17.6, 17.1, 14.2, -4.1, -4.8. 
IR (film): cm-1 2958, 2931, 2859, 1724, 1460, 1301, 1256, 1170, 1095, 1041, 838. 
Elemental analysis: calcd. for C28H46O4Si: C 70.84%, H 9.77%; found: C 71.08%, H 9.55%. 
[]D
20 +12.3 (c 1.1, EtOAc). 
Rf=0.22 (petroleum ether : toluene = 1 : 1). 
 
2.7 (4R,5R,6R,E)-4-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-6,10-dimethylundeca-2,9-
dien-1-ol (13) 
 
Diisobutylaluminum hydride (20 mL of 1.5 M solution in toluene; 30 mmol; 2.6 eq) was added dropwise 
to a cold (‐40 °C) solution of (4R,5R,6R,E)‐ethyl‐4‐(benzyloxy)‐5‐(tert-butyldimethylsilyloxy)‐6,10‐ 
dimethylundeca‐2,9‐dienoate 12 (5.48 g; 11.55 mmol) in dry diethyl ether (165 mL), under an argon 
atmosphere. Stirring was continued for 15 minutes and the reaction was quenched with saturated 
potassium sodium tartrate (50 mL). The resulting biphasic mixture was vigorously stirred for 2 h, until all 
the initially formed gel has redissolved. The organic layer was separated and the aqueous layer was 
additionally extracted with ether (4x100 mL). The combined organic extracts were dried over MgSO4, 
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and concentrated under reduced pressure. Purification by dry‐flash chromatography (eluent: petroleum 
ether : ethyl acetate = 3 : 1) afforded 4.85 g (85%) of alcohol 13, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3) 7.23-7.33 (m, 5H), 5.83 (dtt, J1=0.7, J2=5.5, J3=15.7, 1H), 5.59 (qt, J1=1.5, 
J2=15.7, 1H), 5.07 (t, J=7.2, 1H), 4.55 (d, J=12, 1H), 4.38 (d, J=12, 1H), 4.15 (bs, 2H), 3.80 (t, J=7.2, 1H), 
3.54 (dd, J1=3.1, J2=6.7, 1H), 1.97-2.07 (m, 1H), 1.79-1.88 (m, 1H), 1.67 (s, 3H), 1.59-1.65 (m, 1H), 1.58 (s, 
3H), 1.37-1.46 (m, 1H), 1.32 (bs, 1H, OH), 1.14-1.24 (m, 1H), 0.94 (d, J=6.7, 3H), 0.87 (s, 9H), 0.02 (s, 3H), 
-0.03 (s, 3H). 
13C NMR (125 MHz, CDCl3) 138.9, 132.7, 131.2, 129.1, 128.1, 127.6, 127.2, 124.9, 83.0, 79.2, 70.4, 63.1, 
35.0, 30.5, 26.1, 25.7, 25.6, 18.4, 17.6, 17.3, -3.8, -4.8. 
IR (film): cm-1 2957, 2929, 2860, 1711, 1112. 
Elemental analysis: calcd. for C26H44O3Si:  C 72.17%, H 10.25%; found: C 71.95%, H 10.56%. 
[]D
20 +10.6 (c 1.0, EtOAc). 
Rf=0.39 (petroleum ether : ethyl acetate = 3 : 1). 
 
2.8 ((4R,5R,6R,E)-4-(benzyloxy)-1-bromo-6,10-dimethylundeca-2,9-dien-5-yloxy)(tert-
butyl)dimethylsilane (14) 
 
Triphenylphosphine (3.23 g; 12.3 mmol; 1.1 eq) and carbon tetrabromide (5.92 g; 17.8 mmol; 1.6 eq) 
were added to a cold (0 °C) solution of (4R,5R,6R,E)‐4‐(benzyloxy)‐5‐(tert‐butyldimethylsilyloxy)‐6,10‐ 
dimethylundeca‐2,9‐dien‐1‐ol 13 (4.84 g; 11.2 mmol) in dry dichloromethane (62 mL). The reaction 
mixture was stirred for 15 minutes under an argon atmosphere, and concentrated under reduced 
pressure. The residue was triturated with petroleum ether and the solution was filtered from the 
precipitated solid. The solid was redissolved in a minimal volume of dichloromethane and the trituration 
process was repeated three more times. Silica (25 g) was added to the combined filtrates and the 
mixture was evaporated to dryness. The solid was loaded on a dry‐flash column and eluted (eluent: 
petroleum ether : ethyl acetate = 98 : 2) to give 5.27 g (95%) of bromide 14, as a colorless oil. 
 
1H NMR (200 MHz, CDCl3) 7.21-7.38 (m, 5H), 5.82-6.02 (m, 1H), 5.67 (dd, J1=7.5, J2=15.4, 1H), 5.08 (t, 
J=6.8, 1H), 4.57 (d, J=12.2, 1H), 4.36 (d, J=12.2, 1H), 3.98 (d, J=7.6, 2H), 3.81 (t, J=7.5), 3.53 (dd, J1=3.0, 
J2=7.5), 1.74-2.15 (m, 2H), 1.69 (s, 3H), 1.60 (s, 3H), 1.04-1.55 (m, 3H), 0.95 (d, J=6.8, 3H), 0.88 (s, 9H), 
0.02 (s, 3H), -0.02 (s, 3H). 
13C NMR (50 MHz, CDCl3) 138.5, 133.0, 131.2, 129.5, 128.2, 127.8, 127.3, 124.9, 82.2, 79.1, 70.4, 35.2, 
32.0, 30.5, 26.1, 25.7, 25.6, 18.4, 17.7, 17.3, -3.8, -4.8. 
IR (film): cm-1 2957, 2930, 2858, 1461, 1252, 1100, 1045, 839. 
HRMS (m/z) [M+Na]+ calcd. for C26H43BrO2SiNa: 517.2108; found: 517.2115. 
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Elemental analysis: calcd. for C26H43BrO2Si: C 63.01%, H 8.75%; found: C 62.87%, H 8.99%. 
[]D
20 +11.9 (c 3.6, EtOAc). 
Rf=0.75 (petroleum ether : ethyl acetate = 9 : 1). 
 
2.9 (4R,5R,6R,E)-6-(benzyloxy)-9-bromo-5-(tert-butyldimethylsilyloxy)-4-methylnon-7-enal 
(15) 
 
 
Solid mCPBA (0.726 g 77% mCPBA; 3.24 mmol; 1.3 eq) was added in several portions to the ice cold 
solution of ((4R,5R,6R,E)‐4‐(benzyloxy)‐1‐bromo‐6,10‐dimethylundeca‐2,9‐dien‐5‐yloxy)(tert‐butyl) 
dimethylsilane 14 (1.235 g; 2.49 mmol) in dichloromethane (36 mL). After all the starting material was 
epoxidized (15 min), the reaction mixture was diluted with dichloromethane (200 mL), and washed 
successively with 10% sodium thiosulfate, saturated sodium bicarbonate and brine. The organic layer 
was dried over MgSO4 and solvent evaporated, to yield the crude epoxide. Saturated solution of periodic 
acid in diethyl ether (630 mg H5IO6/150 mL diethyl ether; 2.76 mmol; 1.1 eq) was added to the ethereal 
solution (20 mL) of the crude epoxide, causing the mixture to become  milky white. After 15 minutes the 
fragmentation was complete and the mixture was washed with 10% sodium thiosulfate, saturated 
sodium bicarbonate and brine. The organic phase was dried over MgSO4 and concentrated under 
reduced pressure, to afford 1.13 g of the crude aldehyde 15, which was used directly in the next step, 
without purification. 
 
1H NMR (200 MHz, CDCl3) 9,76 (t, J=1.8, 1H), 7.28-7.36 (m, 5H), 5.97 (dt, J1=7.4, J2=15.6, 1H), 5.71 (dd, 
J1=7.4, J2=15.6, 1H), 4.58 (d, J=11.9, 1H), 4.36 (d, J=11.9, 1H), 3.99 (d, J=7.4, 2H), 3.84 (t, J=7.1, 1H), 3.58 
(dd, J1=3.0, J2=6.5, 1H), 2.23-2.60 (m, 2H), 1.70-1.90 (m, 1H), 1.51-1.69 (m, 1H), 1.34-1.51 (m, 1H), 0.95 
(d, J=6.7, 3H), 0.88 (s, 9H), 0.03 (s, 3H), -0.02 (s, 3H). 
13C NMR (50 MHz, CDCl3) 203.0, 138.3, 132.6, 129.8, 128.2, 127.8, 127.5, 82.1, 78.7, 70.6, 41.9, 34.9, 
31.9, 26.0, 22.7, 17.4, -3.9, -4.8 (one carbon resonance was not observed under the recording 
conditions). 
Rf=0.60 (petroleum ether : ethyl acetate = 4 : 1). 
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2.10 (4R,5R,6R,E)-methyl 6-(benzyloxy)-9-bromo-5-(tert-butyldimethylsilyloxy)-4-
methylnon-7-enoate (16) 
 
To a solution of crude aldehyde 15 (32 mg; 0.068 mmol) in dry DMF (1.2 mL) was added finely powdered 
Oxone® (63 mg; 0.1 mmol; 1.5 eq) and the resulted heterogeneous mixture was stirred 1.5 h at room 
temperature, under an argon atmosphere. The mixture was diluted with diethyl ether (50 mL) and the 
organic extract was washed with 0.5 M hydrochloric acid. The organic layer was dried over MgSO4 and 
concentrated under reduced pressure, to afford the corresponding acid. The crude acid was dissolved in 
diethyl ether (1.5 mL), the solution was cooled to 0 °C and treated with a cold solution of diazomethane 
in ether, until yellow color persists. After additional 30 minutes of stirring, the reaction mixture was 
concentrated at rotovap. Purification of the residue by dry‐flash chromatography (petroleum ether : 
ethyl acetate = 97 : 3) afforded 25.4 mg (75%) of methyl ester 16, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.22-7.34 (m, 5H), 5.92-5.98 (m, 1H), 5.71 (dd, J1=7.5, J2=15.5, 1H), 4.56 (d, 
J=11.5, 1H), 4.36 (d, J=11.5, 1H), 3.95-4.01 (m, 2H), 3.83 (t, J=7, 1H), 3.66 (s, 3H), 3.54 (dd, J1=3, J2=6.5, 
1H), 2.33-2.39 (m, 1H), 2.18-2.24 (m, 1H), 1.76-1.82 (m, 1H), 1.58-1.62 (m, 1H), 1.40-1.48 (m, 1H), 0.94 
(d, J=7, 3H), 0.87 (s, 9H), 0.02 (s, 3H). -0.03 (s, 3H). 
13C NMR (125 MHz, CDCl3)  174.4, 138.4, 132.7, 129.7, 128.2, 127.7, 127.4, 82.1, 78.8, 70.6, 51.4, 35.1, 
32.0, 31.9, 26.1, 25.9, 18.4, 17.2, -3.9, -4.8. 
IR (film): cm-1 2955, 2931, 2885, 2857, 1739, 1103, 836. 
HRMS (m/z) [M+NH4]
+ calcd. for C24H43BrNO4Si: 516.2139; found: 516.2132. 
[]D
20 +15.5 (c 0.95, CHCl3). 
Rf=0.28 (petroleum ether : ethyl acetate = 94 : 6). 
 
2.11 (4R,5R,Z)-methyl 6-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-4-methylnona-6,8-
dienoate (17) 
 
A solution of KHMDS in dry THF (82 µL; c=0.8 M; 0.066 mmol; 1.3 eq) was added to a cold (-78 °C) 
solution of bromide 16 (25 mg; 0.05 mmol) in dry tetrahydrofuran (3.2 mL), under an argon atmosphere. 
The temperature of the mixture was allowed to reach -50 °C during 30 minutes, when a solution of 
tetrakis(triphenylphosphine)palladium(0) (2.9 mg; 5 mol% in 200 L of dry THF) was added. Stirring was 
continued for 1 h at room temperature and the mixture was evaporated to dryness under reduced 
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pressure. The residue was purified by column chromatography (eluent: petroleum ether : ethyl acetate = 
94 : 6) to yield 18.3 mg (87%) of diene 17, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.26-7.41 (m, 5H), 6.70 (dt, J1=10, J2=18, 1H), 5.67 (dd, J1=0.5, J2=10, 1H), 
5.13 (dd, J1=2, J2=18, 1H), 4.97 (dd, J1=2, J2=10, 1H), 4.93 (d, J=11.5, 1H), 4.89 (d, J=11.5, 1H), 3.92 (d, J=5, 
1H), 3.64 (s, 3H), 2.33-2.39 (m, 1H), 2.20-2.26 (m, 1H), 1.88-1.95 (m, 1H), 1.79-1.84 (m, 1H), 1.37-1.44 
(m, 1H), 0.92 (s, 9H), 0.90 (d, J=7, 3H), 0.04 (s, 3H), 0.00 (s, 3H). 
13C NMR (125 MHz, CDCl3)  174.4, 156.7, 137.8, 130.6, 128.4, 127.8, 115.0, 114.0, 76.9, 74.0, 51.4, 36.7, 
32.2, 26.2, 25.9, 18.2, 16.4, -4.4, -5.1. 
IR (film): cm-1 2955, 2931, 2858, 1740, 1255, 838. 
HRMS (m/z) [M+NH4]
+ calcd. for C24H42NO4Si: 436.2878; found: 436.2862. 
[]D
20 +32.5 (c 1.0, CHCl3). 
Rf=0.48 (petroleum ether : ethyl acetate = 9 : 1). 
 
2.12 (1S,2R,3R,4R,5R)-methyl 3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexanecarboxylate (18) 
 
Finely powdered Oxone® (2.9 g; 4.72 mmol; 4 eq) was added in one portion to a solution of aldehyde 19 
(458 mg; 1.18 mmol) in dry DMF (23 mL), and the resulted suspension was stirred at room temperature 
for 18 h. The reaction mixture was diluted with 1M hydrochloric acid (10 mL) and extracted with diethyl 
ether. The organic extract was washed with brine, dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude acid was dissolved in diethyl ether (15 mL), the 
solution was cooled to 0 °C and treated with a cold solution of diazomethane in ether, until yellow color 
persisted. After additional 15 minutes of stirring, the reaction mixture was concentrated at rotavap. 
Purification of the residue by dry‐flash (petroleum ether : ethyl acetate = 97 : 3) afforded 320 mg (65%) 
of methyl ester 18, as a colorless oil. 
 
1H NMR (200 MHz, CDCl3) 7.26-7,38 (m, 5H), 5.81-6.00 (m, 1H), 4.98-5.11 (m, 2H), 4.52 (s, 2H), 3.69 (t, 
J=2.7, 1H), 3.62 (s, 3H), 3.42 (dd, J1=1.7, J2=3.3, 1H), 2.71-2.82 (m, 2H), 1.92-2.01 (m, 1H), 1.45-1.71 (m, 
2H), 0.93 (s, 9H), 0.88 (d, J=7.0, 3H), 0.00 (s, 3H), -0.02 (s, 3H). 
13C NMR (125 MHz, CDCl3)  175.9, 138.7, 138.6, 128.2, 127.5, 127.4, 116.2, 81.6, 72.9, 70.8, 51.2, 43.2, 
42.8, 30.4, 30.1, 25.8, 25.7, 18.0, -4.7, -4.9. 
IR (film): cm-1 2951, 2861, 1739, 1461, 1363, 1256, 1153, 1078. 
Elemental analysis: calcd. for C24H38O4Si: C 68.86%, H 9.15%; found: C 69.24%, H 9.31%. 
[]D
20 +39.5 (c 0.56, EtOAc). 
Rf= 0.72 (petroleum ether : ethyl acetate = 5 : 1). 
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry
This journal is © The Royal Society of Chemistry 2013
S15 
 
2.13 (2R,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexanecarbaldehyde (19) 
 
A) Compound 19 (Cyclization of bromide 15): A freshly distilled pyrrolidine (244 μL; 2.9 mmol; 1.2 eq) 
was added to a solution of crude (4R,5R,6R,E)‐6‐(benzyloxy)‐9‐bromo‐5‐(tert‐butyldimethylsilyloxy)‐4‐
methylnon‐7‐enal 15 from the previous step (1.13 g; ca. 2.4 mmol) in dry tetrahydrofuran (160 mL), 
followed by the addition of tetrakis(triphenylphosphine)palladium(0) (278 mg; 0.24 mmol; 10 mol%), 
under an argon atmosphere. The reaction mixture was stirred 2 h, when TLC indicated the full 
consumption of the starting material. Silica (8 g) was added and the mixture was evaporated to dryness 
under reduced pressure. The solid thus obtained was loaded on a dry‐flash chromatography column and 
eluted (eluent: petroleum ether : ethyl acetate = 95 : 5) to give 0.775 g (83% over 3 steps, from 14) of 
product 19, as a colorless oil (trans/cis = 5 : 1). 
B) Compound 19 (Cyclization of acetate 21): A solution of triphenylphosphine (1.2 mg; 2.6 mol; 20 
mol%) and palladium acetate (0.25 mg; 1.1 mol; 5 mol%) in dry DMSO (50 L) was stirred 15 minutes at 
room temperature, producing a yellowish suspension. A solution of allylic acetate 21 (10.2 mg; 0.023 
mmol) in dry DMSO (20 L) was added to the resulted suspension, followed by the addition of 
pyrrolidine (0.8 L; 9.2 mol; 40 mol%) 10 minutes later. The reaction mixture was stirred overnight at 
room temperature, and then partitioned between dichloromethane and water. The organic layer was 
washed with brine and dried over anhydrous MgSO4, filtered and concentrated under reduced pressure. 
Purification of the residue by column chromatography (petroleum ether : ethyl acetate = 95 : 5) afforded 
3.8 mg (43%) of product 19, as a colorless oil (trans/cis = 5 : 1).  
 
Spectral data for the mixture of diastereoisomers (assignation of peaks in 1H NMR and 13C NMR spectra 
is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer (19) 
1H NMR (500 MHz, CDCl3) 9.52 (d, J=3.1, 1H), 7.23-7.37 (m, 5H), 5.91-6.00 (m, 1H), 5.09-5.15 (m, 2H), 
4.55 (s, 2H), 3.68 (dd, J1=2.2, J2=3.7, 1H), 3.43 (dd, J1=2.5, J2=3.7, 1H), 2.63-2.76 (m, 2H), 1.96-2.05 (m, 
1H), 1.38-1.51 (m, 2H), 0.92 (d, J=6.7, 3H), 0.91 (s, 9H), 0.02 (s, 3H), -0.01 (s, 3H). 
13C NMR (125 MHz, CDCl3)  205.1, 138.5, 138.4, 128.3, 127.7, 127.5, 117.0, 81.8, 73.0, 70.9, 48.6, 41.1, 
29.6, 26.9, 25.8, 18.1, 18.0 -4.7, -4.9. 
 
Minor diastereoisomer (23) 
1H NMR (500 MHz, CDCl3) 9.94 (s, 1H), 7.23-7.37 (m, 5H), 6.20-6.30 (m, 1H), 5.16-5.26 (m, 2H), 4.59 (d, 
J=12.0, 1H), 4.53 (d, J=12.0, 1H), 3.72 (t, J=3.6, 1H), 3.49 (dd, J1=2.2, J2=3.6, 1H), 2.99-3.05 (m, 1H), 2.36-
2.41 (m, 1H), 1.96-2.04 (m, 1H) 1.91 (dt, J1=3.0, J2=13.3, 1H), 1.45-1.51 (m, 1H), 0.90 (s, 9H), 0.89 (d, 
J=6.8, 3H), 0.025 (s, 3H), -0.01 (s, 3H). 
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13C NMR (125 MHz, CDCl3)  204.3, 138.3, 137.8, 128.3, 137.6, 127.2, 116.7, 80.9,72.4, 70.7, 49.8, 41.6, 
29.6, 26.9, 25.8, 18.1, 18.0, -4.6, -4.9. 
 
IR (film): cm-1 2933, 2862, 1725, 1255, 1073, 1040, 837. 
HRMS (m/z) [M+Na]+ calcd. for C23H36O3SiNa: 389.2506; found: 389.2497. 
Elemental analysis: calcd. for C23H36O3Si: C 71.08%, H 9.34%; found: C 71.08%, H 9.49%. 
[]D
20 +42.0 (c 0.2, EtOAc). 
Rf=0.73 (petroleum ether : ethyl acetate = 4 : 1). 
 
2.14 (4R,5R,6R,E)-4-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-6,10-dimethylundeca-2,9-
dienyl acetate (20) 
 
A catalytic amount of 4-dimethylaminopyridine was added to a solution of allylic alcohol 13 (15.6 mg; 
0.036 mmol), acetic anhydride (7 L; 0.072 mmol; 2 eq) and triethylamine (10 L; 0.072 mmol; 2 eq) in 
dry dichloromethane (0.4 mL). After 5 minutes of stirring at room temperature, the volatiles were 
removed under reduced pressure. The residue was purified by column chromatography (eluent: toluene 
: ethyl acetate = 99 : 1), to afford the title compound 20 (14.2 mg; 91%), as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.22-7.35 (m, 5H), 5.77 (dt, J1=6, J2=15.5, 1H), 5.66 (dd, J1=7.5, J2=15.5, 1H), 
5.05 (t, J=6.5, 1H), 4.58 (d, J=11, 2H), 4.55 (d, J=12, 1H), 4.34 (d, J=12, 1H), 3.80 (t, J=7, 1H), 3.53 (dd, 
J1=3, J2=6.5, 1H), 2.07 (s, 3H), 1.96-2.08 (m, 1H), 1.79-1.87 (m, 1H), 1.68 (s, 3H), 1.59 (s, 3H), 1.37-1.43 
(m, 1H), 1.13-1.22 (m, 1H), 0.94 (d, J=7, 3H), 0.87 (s, 9H), 0.01 (s, 3H), -0.03 (s, 3H). 
13C NMR (125 MHz, CDCl3)  170.7, 138.7, 132.0, 131.2, 128.1, 127.7, 127.6, 127.5, 127.2, 124.9, 82.7, 
79.1, 70.4, 64.3, 35.2, 30.6, 26.1, 25.7, 20.9, 18.4, 17.6, 17.3, -3.8, -4.7. 
IR (film): cm-1 2957, 2930, 2857, 1745, 1231, 1095, 836. 
HRMS (m/z) [M+Na]+ calcd. for C28H46O4SiNa: 497.3058; found: 497.3042. 
[]D
20 +13.8 (c 0.9 CHCl3). 
Rf=0.66 (petroleum ether : ethyl acetate = 9 : 1). 
 
2.15 (4R,5R,6R,E)-4-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-6-methyl-9-oxonon-2-enyl 
acetate (21) 
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Solid mCPBA (9.6 mg 77% mCPBA; 0.038 mmol; 1.3 eq) was added in several portions to a cold (-10 °C) 
solution of compound 20 (14 mg; 0.0295 mmol) in dichloromethane (0.6 mL). After all the starting 
material was consumed (30 min), the reaction mixture was diluted with dichloromethane (20 mL), and 
washed successively with 10% sodium thiosulfate, saturated sodium bicarbonate and brine. The organic 
layer was dried over MgSO4 and solvent was evaporated, to yield the crude epoxide. Saturated solution 
of periodic acid in diethyl ether (7.5 mg H5IO6/3 mL diethyl ether; 0.0324 mmol; 1.1 eq) was added to 
the ethereal solution (0.6 mL) of the crude epoxide, causing the mixture to become milky white. After 15 
minutes the fragmentation was complete and the mixture was washed with 10% sodium thiosulfate, 
saturated sodium bicarbonate and brine. The organic phase was dried over MgSO4 and concentrated 
under reduced pressure, to afford 12.7 mg (96%) of the crude aldehyde 21, which was used directly in 
the next step, without purification. 
 
2.16 (1S,2R,3R,4R,5R)-methyl 4-(tert-butyldimethylsilyloxy)-3-hydroxy-5-methyl-2-
vinylcyclohexanecarboxylate and (1S,2R,3R,4R,5R)-methyl 3-(tert-
butyldimethylsilyloxy)-4-hydroxy-5-methyl-2-vinylcyclohexanecarboxylate (24) 
 
Boron‐tribromide (30 μL; 0.315 mmol; 4 eq) was added dropwise to a cold (‐78 °C) solution of methyl 
ester 18 (33 mg; 0.079 mmol) in dry dichloromethane (1.6 mL), under an argon atmosphere. The mixture 
was stirred for 30 minutes at that temperature, then quenched with saturated sodium bicarbonate 
solution (2 mL). After allowing to reach room temperature, the mixture was partitioned between ethyl 
acetate and brine. The organic extract was dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. Purification of the residue by dry‐flash chromatography (petroleum ether : 
ethyl acetate = 5 : 1) afforded 23 mg (85%) of debenzylated products 24 (a mixture of silyl‐ether 
regioisomers), as a colorless oil. The product was used in the next deprotection step, without prior 
separation of regioisomers. 
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2.17 (1S,2R,3R,4R,5R)-methyl 3,4-dihydroxy-5-methyl-2-vinylcyclohexanecarboxylate (25) 
 
 
A solution of concentrated hydrofluoric acid (120 μL), acetonitrile (730 μL) and the mixture of 
regioisomers 24 from the previous step (23 mg; 0.070 mmol) was stirred at room temperature for 4 
days, in a polyethylene vessel. The mixture was partitioned between ethyl acetate and saturated sodium 
bicarbonate, the organic layer was washed with brine and dried over anhydrous MgSO4. The crude 
product was purified by dry‐flash chromatography (petroleum ether : ethyl acetate = 1 : 1), affording 
14.3 mg (91%) of diol 25, as a white solid. The product was recrystallized from n-hexane/ethyl acetate, 
yielding well defined needle‐like colorless crystals, suitable for X‐ray analysis. 
 
mp 89 °C 
1H NMR (500 MHz, CDCl3)  5.84-5.90 (m, 1H), 5.16-5.20 (m, 2H), 3.84 (bs, 1H), 3.78 (t, J=2.8, 1H), 3.63 
(s, 3H), 2.77-2.80 (m, 2H), 2.00-2.05 (m, 1H), 1.77 (bs, 1H), 1.69 (bs, 1H), 1.58-1.62 (m, 2H), 1.00 (d, 
J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  175.9, 137.8, 117.7, 72.9, 72.4, 51.7, 41.9, 41.7, 30.6, 29.4, 17.3. 
IR (film): cm-1 3456, 2955, 2925, 1715, 1284, 1159, 991. 
HRMS (m/z) [M+Na]+ calcd. for C11H18NaO4: 237.1097; found: 237.1090. 
[]D
20 +42.5 (c 0.2, CHCl3). 
Rf=0.30 (petroleum ether : ethyl acetate = 1 : 1) 
ORTEP diagram for diol 25 
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2.18 (1S,2R,3R,4R,5R)-methyl 3-(benzyloxy)-4-methoxy-5-methyl-2-
vinylcyclohexanecarboxylate (26) 
 
 
A) Compound 76 (deprotection of compound 18): A solution of concentrated hydrofluoric acid (250 μL), 
acetonitrile (900 μL) and compound 18 (30 mg; 0.072 mmol) was stirred for 4 days at 40 °C, in a 
polyethylene vessel. The mixture was partitioned between ethyl acetate and saturated sodium 
bicarbonate, the organic layer was washed with brine and dried over anhydrous MgSO4. The crude 
product was purified by dry‐flash chromatography (petroleum ether : ethyl acetate = 4 : 1), affording 
19.5 mg (90%) of alcohol 76, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.26-7.37 (m, 5H), 5.88-5.95 (m, 1H), 5.11 (ddd, J1=0.5, J2=2, J3=17.5, 1H), 
5.03 (dd, J1=2, J2=10, 1H), 4.57 (d, J=12, 1H), 4.52 (d, J=12, 1H) 3.80 (t, J=2.5, 1H), 3.61 (s, 3H), 3.57 (t, 
J=3, 1H), 2.76-2.82 (m, 1H), 2.67-2.72 (m, 1H), 2.00-2.06 (m, 1H), 1.54-1.63 (m, 3H), 0.98 (d, J=7, 3H).  
13C NMR (125 MHz, CDCl3)  175.7, 138.5, 137.9, 128.3, 127.5, 127.3, 116.7, 80.9, 72.9, 70.3, 51.3, 43.3, 
42.7, 30.0, 29.6, 17.3,  
IR (film): cm-1 3529, 3073, 2961, 1744, 1461, 1288. 
HRMS (m/z) [M+NH4]
+ calcd. for C18H28O4N: 322.2013; found: 322.2014. 
[]D
20 +69.3 (c 1.0, CHCl3). 
Rf=0.25 (petroleum ether : ethyl acetate = 4 : 1). 
 
B) Compound 26 (Methylation of compound 75): Sodium hydride (0.7 mg; 0.027 mmol; 2 eq) was added 
to a solution of alcohol 76 (4.2 mg; 0.0138 mmol) in dry THF (0.3 mL), under an argon atmosphere. 
Methyl iodide (17 L; 0.27 mmol; 20 eq) was added after 10 minutes, and stirring was continued for 3 
days at room temperature. The mixture was partitioned between diethyl ether and saturated 
ammonium chloride solution. The organic layer was washed with brine, dried over MgSO4 and 
concentrated under reduced pressure. Purification of the residue by column chromatography (eluent: 
petroleum ether : ethyl acetate = 95 : 5), afforded 2.8 mg (64%) of methylether 26, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.24-7.38 (m, 5H), 5.88-5.95 (m, 1H), 5.10 (ddd, J1=1, J2=2, J3=17.5, 1H), 5.03 
(ddd, J1=0.5, J2=2.5, J3=10.5, 1H), 4.54 (d, J=1, 2H), 3.64 (t, J=3, 1H), 3.60 (s, 3H), 3.35 (s, 3H), 3.15 (t, J=3, 
1H), 2.72-2.77 (m, 1H), 2.59-2.63 (m, 1H), 1.95-2.00 (m, 1H), 1.50-1.59 (m, 2H), 0.98 (d, J=7, 3H).  
13C NMR (125 MHz, CDCl3)  175.7, 138.5, 138.2, 128.3, 127.6, 127.4, 116.5, 79.8, 77.6, 72.9, 58.7, 51.2, 
43.4, 43.1, 30.9, 29.7, 17.5. 
IR (film): cm-1 2927, 2871, 1736, 1156, 1095. 
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HRMS (m/z) [M+Na]+ calcd. for C19H26O4Na: 319.1904; found: 319.1888. 
[]D
20 +72.6 (c 0.3, CHCl3). 
Rf=0.43 (petroleum ether : ethyl acetate = 9 : 1). 
 
2.19 (1S,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-formyl-5-methyl-2-
vinylcyclohexyl benzoate (27) 
 
N-Methyl-O-benzoylhydroxylamine hydrochloride (2.2 mg; 11.6 mol; 1.5 eq) was added to a solution of 
aldehyde 19 (3 mg; 7.7 mol) in dry DMSO (100 L), and the mixture was stirred for 5 days at 50 °C, 
under an argon atmosphere. The mixture was purified by preparative thin layer chromatography 
(eluent: PhMe : EtOAc = 9 : 1), to afford 1.3 mg (33%) of the title compound 27, as a colorless film. 
 
1H NMR (500 MHz, CDCl3) 9.91 (s, 1H), 7.96-8.00 (m, 2H), 7.51-7.55 (m, 1H), 7.40-
7.43 (m, 2H), 7.26-7.37 (m, 5H), 6.18 (dt, J1=9.9, J2=17.0, 1H), 5.29 (dd, J1=2.0, 
J2=17.0, 1H), 5.23 (dd, J1=2.0, J2=9.5, 1H), 4.58 (d, J=12.1, 1H), 4.53 (d, J=12.1, 1H), 
3.69 (t, J=3.0, 1H), 3.57 (dd, J1=2.4, J2=3.3, 1H), 3.17 (dd, J1=2.0, J2=9.5, 1H), 2.70 
(dd, J1=3.7, J2=12.9, 1H), 2.38-2.47 (m, 1H), 1.70 (t, J=12.9, 1H), 0.96 (d, J=6.9, 3H), 
0.91 (s, 9H), 0.02 (s, 3H), -0.01 (s, 3H). 
HRMS (m/z) [M+H]+ calcd. for C30H41O5Si: 509.2718; found: 590.2719. 
Rf=0.80 (petroleum ether : ethyl acetate = 4 : 1). 
 
2.20 ((E)-((2R,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexylidene)methoxy)triisopropylsilane (28) 
 
Triisopropylsilyl trifluoromethanesulfonate (1.85 mL; 6.95 mmol; 4 eq) was added to a solution of 
(2R,3R,4R,5R)‐3‐(benzyloxy)‐4‐(tert‐butyldimethylsilyloxy)‐5‐methyl‐2‐vinylcyclohexanecarbaldehyde 19 
(0.675 g; 1.74 mmol) and triethylamine (4.3 mL; 10.42 mmol; 6 eq) in dry dichloromethane (4.3 mL). The 
mixture was stirred under argon at 50 °C for one hour, then diluted with petroleum ether (100 mL) and 
washed with 10% sodium thiosulfate, saturated sodium bicarbonate and brine. The organic layer was 
dried over MgSO4 and concentrated under reduced pressure. Purification of the residue by dry flash 
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chromatography (eluent: petroleum ether : ethyl acetate = 97 : 3), followed by additional drying at high 
vacuum (30 °C, 0.1 mmHg, to remove the residues of triisopropylsilanol) afforded 0.935 g (99%) of 
silylenolether 28, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3) 7.29-7.34 (m, 5H), 6.05-6.13 (m, 2H), 5.06-5.15 (m, 2H), 4.55 (s, 2H), 3.74 
(dd, J1=2.7, J2=4.9, 1H), 3.38 (dd, J1=3.6, J2=4.9, 1H), 3.14 (bd, J=7.7, 1H), 2.51 
(dd, J1=4.1,J2=13.2, 1H), 1.90-1.97 (m, 1H), 1.82-1.90 (m, 1H), 1.10-1.19 (m, 
3H), 1.08 (d, J=6.3, 18H), 0.89-0.91 (m, 12H), 0.03 (s, 3H), 0.01 (s, 3H). 
13C NMR (125 MHz, CDCl3) 139.2, 137.6, 134.4, 128.1, 127.3, 127.2, 118.4, 
116.1, 82.4, 72.4, 72.1, 44.1, 32.1, 26.4, 25.8, 18.1, 17.8, 17.7, 12.0, -4.5, -4.9. 
IR (film): cm-1 2953, 2892, 2865, 1464, 1106, 1073, 834. 
HRMS (m/z) [M+Na]+ calcd. for C32H56O3Si2Na: 567.3660; found: 567.3662. 
Elemental analysis: calcd. for C32H56O3Si2: C 70.53%, H 10.36%; found: C 70.14%, H 10.57%. 
[]D
20 +19.0 (c 0.2, EtOAc). 
Rf=0.83 (petroleum ether : ethyl acetate = 98 : 2). 
 
2.21 (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-hydroxy-5-methyl-2-
vinylcyclohexanecarbaldehyde (29) and (1S,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-
butyldimethylsilyloxy)-1-hydroxy-5-methyl-2-vinylcyclohexanecarbaldehyde (30) 
 
A) Sharpless asymmetric dihydroxylation: To a solution of silylenolether 28 (177 mg; 0.325 mmol) in tert-
butanol/water mixture (1:1.4; 2.4 mL) was added (DHQD)2PHAL (25 mg; 10 mol%), K3[Fe(CN)6] (214 mg; 
0.65 mmol; 2 eq), potassium carbonate (135 mg; 0.975 mmol; 3 eq) and potassium osmate dihydrate (18 
mg; 15 mol%). The mixture was stirred for 48 h at 4 °C and saturated sodium sulfite solution (1 mL) was 
added. After additional 24 h of stirring, the mixture was partitioned between ethyl acetate (50 mL) and 
water (15 mL). The organic layer was dried over MgSO4 and concentrated under reduced pressure. 
Purification of the residue by dry flash chromatography (eluent: petroleum ether : ethyl acetate = 96 : 
4), afforded 68 mg of the unreacted starting compound 28, followed by 76 mg (58% or 94% based on 
recovered starting material) of product 30, as a colorless oil. 
If equivalent amount of (DHQ)2PHAL was used instead of (DHQD)2PHAL, the same stereoisomer was 
isolated in 39% yield. 
B) Epoxidation with mCPBA: Solid mCPBA (77%; 14.7 mg; 0.085 mmol; 2.5 eq) was added to a cold (-30 
°C) solution of silylenolether 28 (20 mg; 0.034 mmol) in dichloromethane (2 mL). After 1.5 h of stirring, 
HF-pyridine complex (50 L) was added and stirring was continued for one hour at room temperature. 
Silica (100 mg) was added to the mixture, all volatiles were removed on rotovap and the residue was 
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purified by column chromatography (eluent: petroleum ether : ethyl acetate = 9 : 1), affording 11.7 mg 
(85%) of the diastereoisomeric mixture of 29 and 30 (29 : 30 = 1.5 : 1), as a colorless oil. 
C) Epoxidation with MMPP: Magnesium monoperoxyphthalate (80%; 23 mg; 34 mol; 1 eq) was added 
to a solution of silylenolether 28 (20 mg; 34 mol ) in ethanol (3 mL). After 3 h of stirring, HF-pyridine 
complex (50 L) was added and stirring was continued for one hour at room temperature. Silica (100 
mg) was added to the mixture, all volatiles were removed on rotovap and the residue was purified by 
column chromatography (eluent: petroleum ether : ethyl acetate = 9 : 1), to afford 6.3 mg (46%) of the 
mixture of diastereoisomers 29 and 30 (29 : 30 = 1 : 4), as a colorless oil. 
D) Epoxidation with DMDO: A freshly prepared9 solution of dimethyldioxirane (0.75 mL) was added 
dropwise to a solution of silylenolether 28 (20 mg; 0.034 mmol) in dry dichloromethane (1.2 mL), during 
10 minutes. Epoxide HF-pyridine complex (100 L) was added to this solution and stirring was continued 
for 2 h at room temperature. Silica (100 mg) was added to the mixture, all volatiles were removed on 
rotovap and the residue was purified by column chromatography (eluent: petroleum ether : ethyl 
acetate = 9 : 1), to afford 11.3 mg (82%) of product 30, as a colorless oil. 
E) Epoxidation with a modified Davis' oxaziridine: Solution of silylenolether 28 (3.4 mg; 5.8 mmol) and 2-
benzenesulphonyl-3-(p-nitrophenyl)oxaziridine (70% purity; 2.8 mg; 1.1 eq) in chloroform (0.2 mL) was 
stirred for 3 h at 65 °C. The reaction mixture was cooled to room temperature, HF-pyridine complex (50 
L) was added and stirring was continued for an additional hour. The reaction mixture was purified by 
column chromatography (eluent: petroleum ether : ethyl acetate = 9 : 1), to afford 2.0 mg (86%) of 
product 30, as a colorless oil. 
 
Spectral data for isomer 29 
1H NMR (500 MHz, CDCl3)  9.49 (s, 1H), 7.33-7.39 (m, 5H), 6.06-6.14 (m, 1H), 5.14-5.16 (m, 1H), 5.09-
5.13 (m, 1H), 4.59 (s, 2H), 4.38 (s, 1H), 3.74 (t, J=2.5, 1H), 3.57 (t, J=3, 1H), 2.80 (dd, J1=2.5, J2=9, 1H), 
2.18-2.23 (m, 1H), 1.66 (t, J=13, 1H), 1.34 (dd, J1=4, J2=13, 1H), 0.93 (d, J=7, 3H), 0.89 (s, 9H), 0.01 (s, 3H), 
-0.04 (s, 3H).  
13C NMR (125 MHz, CDCl3) 204.9, 137.2, 134.4, 128.6, 128.2, 127.9, 118.8, 83.8, 80.2, 73.8, 70.4, 43.1, 
34.9, 25.7, 25.5, 18.0, 17.7, -4.7, -4.9. 
IR (film): cm-1 3509, 2955, 2931, 2858, 1737, 1255, 1068, 1023. 
HRMS (m/z) [M+Na]+ calcd. for C23H36O4SiNa: 427.2275; found: 427.2282. 
[]D
20 +36.6 (c 1.0, CHCl3). 
Rf=0.31 (petroleum ether : ethyl acetate = 9 : 1). 
 
Spectral data for isomer 30 
1H NMR (500 MHz, CDCl3)  10.06 (s, 1H), 7.26-7.44 (m, 5H), 5.72 (dt, J1=10, J2=17, 1H), 5.25 (ddd, J1=0.5, 
J2=2, J3=17, 1H), 5.22 (dd, J1=2, J2=10, 1H), 4.61 (d, J=3, 2H), 3.80 (t, J=3, 1H), 3.64 (t, J=3, 1H), 3.58 (s, 
1H), 2.85 (dd, J1=3, J2=10, 1H), 2.36-2.41 (m, 1H), 1.86 (t, J=13.5, 1H), 1.58 (dd, J1=3.5, J2=13.5, 1H), 0.98 
(d, J=6.5, 3H), 0.94 (s, 9H), 0.08 (s, 3H), 0.05 (s, 3H). 
13C NMR (125 MHz, CDCl3)  204.8, 137.9, 133.5, 128.5, 127.9, 127.5, 112.0, 82.7, 78.2, 73.4, 70.0, 50.6, 
35.7, 28.9, 25.8, 18.2, 18.0, -4.6, -4.9. 
IR (film): cm-1 3514, 2955, 2931, 2858, 1714, 1254, 1066. 
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HRMS (m/z) [M+Na]+ calcd. for C23H36O4SiNa: 427.2275; found: 427.2263. 
[]D
20 +55.8 (c 0.65, CHCl3). 
Rf=0.21 (petroleum ether : ethyl acetate = 94 : 6). 
 
2.22 ((1R,2S,3R,4R,5R)-1-acetoxy-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexyl)methylene diacetate (32) 
 
A pinch of scandium triflate was added to a cold (0 °C) solution of hydroxyaldehyde 29 (3.3 mg; 8.2 
mol) in acetic anhydride (150 L), under an argon atmosphere. After 3 h of stirring, the solution was 
diluted with dichloromethane (15 mL) and washed with saturated sodium bicarbonate and brine. The 
organic layer was dried over MgSO4 and concentrated under reduced pressure. Purification of the 
residue by dry flash chromatography (eluent: petroleum ether : ethyl acetate = 9 : 1), afforded 3.4 mg 
(76%) of product 32, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.30-7.35 (m, 5H), 6.99 (s, 1H), 6.31-6.39 (m, 1H), 5.14 (dd, J1=1.0, J2=10.0, 
1H), 5.00 (ddd, J1=0.5, J2=2.0, J3=17.0, 1H), 4.53 (d, J=11.5, 1H), 4.46 (d, J=11.5, 1H), 3.72 (bt, J=2.5, 1H), 
3,41 (t, J=3.5, 1H), 2.73 (dd, J1= 3.0, J2= 7.0, 1H), 2.70 (t, J=2.5, 1H), 2.04 (s, 3H), 2.03 (s, 3H), 1.84 (s, 3H), 
1.69 (dd, J1=1.0, J2=13.0, 1H), 0.92 (s, 9H), 0.90 (d, J=3.0, 3H), 0.04 (s, 3H), 0.03 (s, 3H). 
13C NMR (125 MHz, CDCl3)  170.0, 168.6, 168.1, 138.8, 136.3, 128.2, 127.5, 127.3, 117.2, 88.8, 84.6, 
84.5, 73.5, 70.7, 44.6, 27.4, 26.6, 25.7, 22.2, 20.8, 20.6, 18.0, 17.8, -4.7, -4.8. 
IR (film): cm-1  2955, 2931, 2857, 1771, 1741, 1247, 1223, 1200, 1084, 1038, 1012. 
HRMS (m/z) [M+NH4]
+ calcd. for C29H48O8NSi: 566.3144; found: 566.3143. 
[]D
20 -6.2 (c 0.1, CHCl3). 
Rf=0.51 (petroleum ether : ethyl acetate = 4 : 1). 
 
2.23 (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-(hydroxymethyl)-5-
methyl-2-vinylcyclohexanol (34) 
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Sodium borohydride (11.2 mg; 0.30 mmol; 2 eq) was added to a solution of hydroxyaldehyde 29 (60 mg; 
0.15 mmol) in tetrahydrofuran/water mixture (5:1; 4.2 mL) and the stirring was continued for 30 
minutes at room temperature. The mixture was partitioned between ethyl acetate and water, and the 
organic layer was washed with brine. The organic extract was dried over MgSO4 and concentrated under 
reduced pressure. The crude product was purified by dry flash chromatography (eluent: petroleum ether 
: ethyl acetate = 2 : 1), to give 60.2 mg (100%) of diol 34, as a colorless, viscous oil. 
 
1H NMR (500 MHz, CDCl3)  7.28-7.34 (m, 5H), 6.24 (dt, J1=10, J2=17, 1H), 5.16 (dd, J1=2, J2=10, 1H), 5.11 
(ddd, J1=0.5, J2=2, J3=17, 1H), 4.58 (d, J=12, 1H), 4.55 (d, J=12, 1H), 4.20 (s, 1H), 3.72 (t, J=3, 1H), 3.53 (t, 
J=3, 1H), 3.47-3.49 (m, 1H), 3.29 (dd, J1=6.5, J2=10.5, 1H), 2.48 (dd, J1=2.5, J2=9.5, 1H), 2.14-2.19 (m, 1H), 
1.79 (bs, 1H), 1.56 (dd, J1=3.5, J2=13, 1H), 1.48 (t, J=13, 1H), 0.93 (d, J=6.5, 3H), 0.88 (s, 9H), 0.01 (s, 3H), -
0.04 (s, 3H). 
13C NMR (125 MHz, CDCl3)  137.5, 136.7, 128.5, 128.1, 127.8, 117.2, 85.7, 73.7, 73.6, 70.7, 69.4, 44.0, 
36.6, 26.4, 25.7, 18.0, 17.9, -4.7, -4.9. 
IR (film): cm-1 3480, 2954, 2929, 2858, 1254, 1065, 1024. 
HRMS (m/z) [M+K]+ calcd. for C23H38O4KSi: 445.2171; found: 445.2184. 
[]D
20 +42.8 (c 0.6, CHCl3). 
Rf=0.29 (petroleum ether : ethyl acetate = 3 : 1). 
 
2.24 ((1R,2S,3R,4R,5R)-1-acetoxy-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexyl)methyl acetate (35) 
 
Acetic anhydride (60 L; 0.619 mmol; 24 eq) and 4-dimethylaminopyridine (9.5 mg; 0.078 mmol; 3 eq) 
were added to a solution of diol 34 (10.5 mg; 0.026 mmol) in dry triethylamine (300 L) and the mixture 
was stirred for 4 days at 70 °C, under an argon atmosphere. The mixture was partitioned between 
dichloromethane and 5% hydrochloric acid, the organic layer was washed with saturated sodium 
bicarbonate solution and brine. The organic extract was dried over MgSO4 and concentrated under 
reduced pressure. Purification of the residue by column chromatography (eluent: petroleum ether : 
ethyl acetate = 9 : 1) afforded 6.3 mg (50%) of diacetate 35, as a pale yellow oil.  
 
1H NMR (500 MHz, CDCl3)  7.26-7.35 (m, 5H), 6.23 (dt, J1=10, J2=17, 1H), 5.12 (dd, J1=2.5, J2=10.5, 1H), 
5.05 (dd, J1=1.5, J2=17, 1H), 4.61 (d, J=11, 1H), 4.56 (d, J=12, 1H), 4.49 (d, J=12, 1H), 4.08 (d, J=10.5, 1H), 
3.73 (s, 1H), 3.42 (t, J=3.5, 1H), 2.65 (dd, J1=3.5, J2=9.5, 1H), 2.37 (dd, J1=2.5, J2=14, 1H), 2.10-2.15 (m, 
1H), 2.01 (s, 3H), 1.95 (s, 3H), 1.63 (dd, J1=13, J2=14.5, 1H), 0.92 (s, 9H), 0.89 (d, J=7, 3H), 0.04 (s, 3H), 
0.03 (s, 3H). 
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13C NMR (125 MHz, CDCl3)  170.3, 170.2, 139.0, 136.2, 128.1, 127.3, 126.9, 117.4, 84.0, 82.7, 73.2, 70.8, 
65.5, 45.2, 30.6, 26.5, 25.7, 22.1, 20.8, 18.0, 17.9, -4.7, -4.8. 
IR (film): cm-1 2956, 2931, 2858, 1741, 1248, 1223, 1076, 1035. 
HRMS (m/z) [M+Na]+ calcd. for C27H42O6SiNa: 513.2643; found: 513.2622. 
[]D
20 +3.7 (c 0.4, CHCl3). 
Rf=0.65 (petroleum ether : ethyl acetate = 4 : 1). 
2.25 (3S,4R,5R,6R)-4-(benzyloxy)-5-(tert-butyldimethylsilyloxy)-6-methyl-3-
vinylcycloheptane-1,2-dione (36) 
 
Ethyl bromoacetate (7.7 L; 0.069 mmol; 5 eq) and zinc powder (3.6 mg; 0.055 mmol; 4 eq) were added 
to a solution of hydroxyaldehyde 29 (5.6 mg; 0.014 mmol) in benzene/diethyl ether mixture (1:1; 0.6 
mL). A small crystal of iodine was added and the mixture was heated to 70 °C. After 1 h of stirring at that 
temperature, the mixture was diluted with ethyl acetate and washed with brine. The organic extract was 
dried over MgSO4 and concentrated under reduced pressure. The crude product was redissolved in dry 
dichloromethane (400 L) and treated with Dess-Martin's periodinane (11.1 mg; 0.026 mmol; 3 eq). 
After the oxidation was complete (2.5 h), silica (100 mg) was added to the mixture and volatiles were 
evaporated under reduced pressure. Purification of the residue by column chromatography (eluent: 
petroleum ether : ethyl acetate = 9 : 1) afforded 2.7 mg (49%) of the title compound 36. 
 
1H NMR (500 MHz, CDCl3)  7.22-7.33 (m, 5 H), 6.28-6.45 (m, 1H), 5.24-5.30 (m, 1H), 5.09-5.13 (m, 1H), 
4.62 (d, J=12.0, 1H), 4.43 (d, J=12.0, 1H), 4.12 (dd, J1=0.5, J2=8.5, 1H), 3.78-3.79 (m, 1H), 3.70-3.71 (m, 
1H), 3.07 (dd, J1=12.0, J2=2.0, 1H), 2.34-2.41 (m, 1H), 2.27 (dd, J1=1.0, J2=12.0, 1H), 1.03 (d, J=7.0, 3H), 
0.93 (s, 9H), 0.05 (s, 3H), -0.01 (s, 3H). 
13C NMR (125 MHz, CDCl3)  198.1, 196.1, 137.2, 134.4, 128.5, 128.1, 127.9, 118.0, 84.7, 73.4, 73.0, 53.1, 
41.4, 31.8, 25.8, 20.6, 18.0, -4.1, -4.9. 
IR (film): cm-1 2955, 2929, 2856, 1716, 1253, 1075. 
HRMS (m/z) [M+H]+ calcd. for C23H35O4Si: 403.2299; found: 403.2286. 
[]D
20 +25.7 (c 0.4, CHCl3). 
Rf=0.62 (petroleum ether : ethyl acetate = 4 : 1). 
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2.26 (2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-
vinylcyclohexanone (37) 
 
Solid mCPBA (427 mg 77% mCPBA; 1.89 mmol; 1.1 eq) was added to a solution of ((E)‐((2R,3R,4R,5R)‐3‐
(benzyloxy)‐4‐(tert‐butyldimethylsilyloxy)‐5‐methyl‐2‐vinylcyclohexylidene)methoxy)triisopropylsilane 
28 (0.938 g; 1.72 mmol) in dry dichloromethane (25 mL), and the resulting mixture was stirred at room 
temperature for 15 minutes, when TLC indicated the full consumption of the starting material. A 
saturated ethereal solution of periodic acid (470 mg H5IO6 in 130 mL diethyl ether; 2.06 mmol; 1.2 eq) 
was added and stirring was continued for 2 h. The milky white suspension was diluted with diethyl ether 
(100 mL) and washed successively with 10% sodium thiosulfate, sodium bicarbonate and brine. The 
organic extract was dried over MgSO4 and concentrated under reduced pressure. Purification of the 
residue by dry flash chromatography (eluent: petroleum ether : ethyl acetate = 94 : 6) afforded 560 mg 
(87%) of cyclohexanone 37, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3) 7.26-7.38 (m, 5H), 6.24 (ddd, J1=8.9, J2=10.3, J3=17.6, 1H) 5.23 (dd, J1=10.4, 
J2=1.6, 1H), 5.07 (d, J=17.5, 1H), 4.57 (d, J=12.0, 1H), 4.49 (d, J=12.0, 1H), 3.79 (t, J=3.5, 1H), 3.72 (bd, 
J=2.8, 1H), 3.47 (dd, J1=3.2, J2=8.8, 1H), 2.30-2.50 (m, 2H), 2.14 (dd, J1=2.7, J2=12.2, 1H), 0.97 (d, J=6.4, 
3H), 0.91 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H). 
13C NMR (125 MHz, CDCl3) 209.3, 138.0, 133.9, 128.4, 127.8, 127.7, 117.9, 86.1, 73.1, 70.9, 53.7, 44.0, 
33.1, 25.8, 18.0, 17.9, -4.6, -4.8. 
IR (film): cm-1 2955, 2930, 2886, 2858, 1719, 1254, 1064, 836. 
HRMS (m/z) [M+H]+ calcd. for C22H35O3Si: 375.2350; found 375.2352. 
Elemental analysis: calcd. for C22H34O3Si: C 70.54%, H 9.15%; found: C 70.50%, H 9.03%. 
[]D
20 +24.0 (c 0.2, EtOAc). 
Rf=0.40 (petroleum ether : ethyl acetate = 95 : 5). 
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2.27 (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-1-
(trimethylsilyloxy)-2-vinylcyclohexanecarbonitrile (38) and (1R,2S,3R,4R,5R)-3-
(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-hydroxy-5-methyl-2-
vinylcyclohexanecarbonitrile (39) 
 
Zinc iodide (7 mg; 0.022 mmol; 6 mol%) and a freshly distilled trimethylsilyl cyanide (50 L; 0.400 mmol; 
3 eq) were added to a solution of ketone 37 (50 mg; 0.133 mmol) in dry dichloromethane (2 mL). After 
15 minutes, silica (300 mg) was added and the mixture was evaporated to dryness. The residue was 
purified by column chromatography (eluent: petroleum ether : ethyl acetate = 97 : 3), to afford 33.6 mg 
(54%) of TMS-protected cyanohydrin 38 and 19.6 mg (36%) of free cyanohydrin 39, as colorless oils. 
 
Spectral data for TMS-protected cyanohydrin 38 
1H NMR (500 MHz, CDCl3)  7.28-7.40 (m, 5H), 6.21 (dt, J1=9.5, J2=17.5, 1H), 5.26-5.31 (m, 2H), 4.54 (d, 
J=12, 1H), 4.50 (d, J=12, 1H), 3.71 (bs, 1H), 3.42 (t, J=3.5, 1H), 2.52 (dd, J1=3.5, J2=9.5, 1H), 2.22-2.32 (m, 
1H), 2.01 (t, J=13.5, 1H), 1.79 (dd, J1=2.5, J2=13.5, 1H), 0.91 (s, 9H), 0.90 (d, J=6.5, 3H), 0.22 (s, 9H), 0.05 
(s, 3H), 0.04 (s, 3H). 
13C NMR (125 MHz, CDCl3)  138.8, 135.0, 128.1, 127.2, 126.7, 121.8, 118.9, 82.1, 73.1, 71.9, 70.8, 48.3, 
39.6, 25.7, 18.0, 17.5, 1.6, 1.1, -4.6, -4.8. 
IR (film): cm-1 2956, 2931, 2860, 1255, 1114, 1064, 842. 
HRMS (m/z) [M+K]+ calcd. for C26H43NO3Si2K: 512.2413; found: 512.2416. 
[]D
20 +12.1 (c 1.0, CHCl3). 
Rf=0.62 (petroleum ether : ethyl acetate = 95 : 5). 
 
Spectral data for cyanohydrin 39 
1H NMR (500 MHz, CDCl3)  7.28-7.40 (m, 5H), 6.19-6.26 (m, 1H), 5.35-3.39 (m, 2H), 4.59 (d, J=11.5, 1H), 
4.56 (d, J=11.5, 1H), 4.51 (s, 1H), 3.69 (bs, 1H), 3.60 (t, J=3, 1H), 2.73 (dd, J1=2.5, J2=9, 1H), 2.15-2.20 (m, 
1H), 1.96 (dd, J1=4, J2=13.5, 1H), 1.89 (t, J=13.5, 1H), 0.93 (d, J=7, 3H), 0.88 (s, 9H), 0.00 (s, 3H), -0.05 (s, 
3H). 
13C NMR (125 MHz, CDCl3)  136.6, 133.2, 128.7, 128.5, 128.0, 120.7, 120.1, 82.9, 74.1, 72.0, 70.0, 45.1, 
39.8, 25.7, 25.4, 17.9, 17.2, -4.7, -4.9. 
IR (film): cm-1 3455, 2955, 2930, 2858, 1758, 1462, 1255, 1059, 843. 
HRMS (m/z) [M+H]+ calcd. for C23H36NO3Si: 402.2459; found: 402.2461. 
[]D
20 +10.4 (c 1.0, CHCl3). 
Rf=0.22 (petroleum ether : ethyl acetate = 95 : 5). 
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2.28 (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-5-methyl-1-
(trimethylsilyl)ethynyl)-2-vinylcyclohexanol (40) 
 
A solution of n-butyl lithium in hexanes (1.5 M; 110 L; 0.16 mmol; 3 eq) was added dropwise to a cold 
(-78 °C) solution of trimethylsilylacetylene (25 L; 0.16 mmol; 3 eq) in dry tetrahydrofuran (1 mL), under 
an argon atmosphere. After 45 minutes of stirring at that temperature, a solution of ketone 37 (20 mg; 
0.053 mmol; 1 eq) in dry THF (1 mL) was added. Stirring was continued for 20 minutes at -78 °C, 
followed by 15 minutes at room temperature. The reaction mixture was partitioned between water and 
diethyl ether and the organic layer was washed with brine. The organic extract was dried over MgSO4 
and concentrated under reduced pressure. The residue was purified by column chromatography (eluent: 
petroleum ether : ethyl acetate = 96 : 4), to afford 21 mg (83%) of product 40, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.28-7.35 (m, 5H), 6.23-6.31 (m, 1H), 5.24-5.26 (m, 1H), 5.17-5.21 (m, 1H), 
4.57 (s, 2H), 4.33 (s, 1H), 3.71 (t, J=2.5, 1H), 3.60 (t, J=3.5, 1H), 2.58 (dd, J1=2.5, J2=9, 1H), 2.10-2.18 (m, 
1H), 1.82 (dd, J1=4, J2=13, 1H), 1.77 (t, J=13, 1H), 0.90 (d, J=7, 3H), 0.89 (s, 9H), 0.14 (s, 9H), 0.01 (s, 3H), -
0.03 (s, 3H). 
13C NMR (125 MHz, CDCl3)  137.2, 135.4, 128.5, 128.1, 127.8, 17.8, 108.6, 87.2, 83.5, 73.8, 71.0, 70.5, 
46.8, 41.8, 26.1, 25.8, 18.0, 17.5, -0.02, -4.65. -4.86. 
IR (film): cm-1 3494, 2956, 2930, 1252, 1059, 841. 
HRMS (m/z) [M+K]+ calcd. for C27H44O3Si2K: 511.2461; found: 511.2451. 
[]D
20 +148 (c 0.1, CHCl3). 
Rf=0.15 (petroleum ether : ethyl acetate = 96 : 4). 
 
2.29 (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-ethynyl-5-methyl-2-
vinylcyclohexanol (41) 
 
A finely powdered potassium carbonate (29 mg; 0.21 mmol; 5 eq) was added to a solution of TMS-
alkyne 40 (20 mg; 0.042 mmol) in methanol (2.8 mL) and the resulted yellow suspension was stirred for 
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1 h at room temperature. After the reaction was complete, the most of methanol was evaporated and 
the residue was partitioned between 1M HCl and ether. The organic extract was washed with brine and 
dried over MgSO4. The solution was concentrated under reduced pressure and the crude product was 
purified by column chromatography (eluent: petroleum ether : ethyl acetate = 94 : 6), to give 15 mg 
(88%) of alcohol 41, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.26-7.33 (m, 5H), 6.27-6.25 (m, 1H), 5.22-5.29 (m, 2H), 4.57 (d, J=2, 2H), 
4.35 (s, 1H), 3.69 (t, J=2.5, 1H), 3.59 (t, J=2.5, 1H), 2.63 (dd, J1=2.5, J2=9, 1H), 2.40 (s, 1H), 2.13-2.18 (m, 
1H), 1.86 (dd, J1=4, J2=13, 1H), 1.80 (t, J=13, 1H), 0.91 (d, J=7, 3H), 0.88 (s, 9H). 
13C NMR (125 MHz, CDCl3)  137.1, 135.6, 128.5, 128.2, 127.8, 118.0, 86.9, 83.7, 73.9, 71.0, 70.5, 46.6, 
41.9, 26.0, 25.7, 18.0, 17.5, -4.7, -4.9.  
IR (film): cm-1 2954, 2929, 2858, 1253, 1056, 840. 
HRMS (m/z) [M+K]+ calcd. for C24H36O3K: 439.2065; found: 439.2051. 
[]D
20 +12.7 (c 1.0, CHCl3). 
Rf=0.31 (petroleum ether : ethyl acetate = 9 : 1). 
 
2.30 (1R,2S,3R,4R,5R)-3-(benzyloxy)-1-ethynyl-5-methyl-2-vinylcyclohexane-1,4-diol (42) 
 
 
A solution of compound 41 (10 mg; 0.025 mmol), acetonitrile (0.5 mL) and 50% hydrofluoric acid (80 L) 
in a polyethylene flask was heated to 50 °C over 4 days. The mixture was cooled to room temperature 
and partitioned between ethyl acetate and water. The organic layer was washed with saturated sodium 
bicarbonate solution and brine and dried over MgSO4. The solution was concentrated under reduced 
pressure and the crude product was purified by column chromatography (eluent: petroleum ether : 
ethyl acetate = 3 : 1), to afford 4.5 mg (63%) of diol 42, as a colorless, viscous film. 
 
1H NMR (500 MHz, CDCl3) 7.25-7.40 (m, 5H), 6.25-6.34 (m, 1H), 5.27-5.33 (m, 2H), 4.59 (q, J=11.3, 2H), 
4.33 (s, 1H), 3.86 (bs, 1H), 3.78 (t, J=3.2, 1H), 2.66 (dd, J1=2.4, J2=8.6, 1H), 2.41 (s, 1H), 2.18-2.29 (m, 1H), 
1.93 (dd, J1=3.8, J2=13.7, 1H), 1.82 (t, J=13.7, 1H), 1.01 (d, J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  137.3, 135.1, 128.7, 128.3, 127.9, 118.6, 86.8, 83.3, 74.1, 71.5, 70.6, 70.0, 
46.6, 41.7, 25.8, 17.0. 
IR (film): cm-1 3439, 3300, 2923, 1406, 1062, 1029, 995. 
HRMS (m/z) [M+Na]+ calcd. for C18H22O3Na: 309.1461; found: 309.1463. 
[]D
20 +32.0 (c 0.2, CHCl3). 
Rf=0.44 (petroleum ether : ethyl acetate = 2 : 1). 
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2.31 (1R,1'R,2S,2'S,3R,3'R,4R,4'R,5R,5'R)-1,1'-(buta-1,3-diyne-1,4-diyl)bis(3-(benzyloxy)-5-
methyl-2-vinylcyclohexane-1,4-diol) (43) 
 
A suspension of palladium acetate (0.12 mg; 0.5 mol; 10 mol%), anhydrous copper(II) chloride (1.8 mg; 
13.1 mol; 2.5 eq), ammonium acetate (0.4 mg; 5.2 mol; 1 eq) and propylene oxide (1.8 L; 26.2 mol; 
5 eq) in dry THF (350 L) was stirred for 30 minutes at room temperature. The atmosphere in the flask 
was replaced with carbon monoxide and a solution of alkyne 42 (1.5 mg; 5.2 mol; 1 eq) in dry THF (300 
L) was added. The reaction mixture was stirred for 40 h at 50 °C and then evaporated to dryness. The 
crude product was purified by column chromatography (eluent: petroleum ether : ethyl acetate = 1 : 1), 
to give 0.7 mg (50%) of compound 43, as a colorless film. 
 
1H NMR (500 MHz, CDCl3)  7.27-7.35 (m, 5H), 6.18-6.25 (m, 1H), 5.26-5.30 (m, 2H), 4.57 (q, J=11, 2H), 
4.27 (s, 1H), 3.82 (bs, 1H), 3.76 (bt, J=3.0, 1H), 2.63 (dd, J1=2.5, J2=9.0, 1H), 2.18-2.22 (m, 1H), 1.88 (dd, 
J1=3.5, J2=14, 1H), 1.78 (t, J=14, 1H), 1.46 (d, J=3, 1H), 0.98 (d, J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  137.1, 134.5, 128.5, 128.2, 127.7, 118.9, 83.0, 81.5, 74.0, 71.1, 70.0, 67.9, 
46.3, 41.3, 25.6, 16.7. 
IR (film): cm-1 3441, 2925, 1406, 1063, 994. 
HRMS (m/z) [M+Na]+ calcd. for C36H42O6Na: 593.2873; found: 593.2863. 
Rf=0.17 (petroleum ether : ethyl acetate = 2 : 1). 
 
2.32 (Z)-methyl 2-((4R,5S,6R,7R,8R)-6-(benzyloxy)-7-hydroxy-8-methyl-2-oxo-5-vinyl-1-
oxaspiro[3.5]nonan-3-ylidene)acetate (44) 
  
To a solution of alkyne 42 (1.0 mg; 3.5 mol) in dry methanol (0.4 mL), bis(acetonitril)palladium(II) 
chloride (0.9 mg; 3.5 mol; 1 eq) was added and atmosphere in the flask was replaced with carbon 
monoxide. The solution was heated at 55 °C for 30 minutes, then cooled to room temperature and 
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evaporated to dryness. The crude product was purified by column chromatography (eluent: petroleum 
ether : ethyl acetate = 2 : 1), to give 1.0 mg (77%) of -lactone 44, as a colorless film. 
 
1H NMR (500 MHz, CDCl3)  7.27-7.34 (m, 5H), 6.04-6.10 (m, 1H), 5.81 (s, 1H), 
5.21 (dd, J1=1.5, J2=10, 1H), 5.13 (dd, J1=1.0, J2=17, 1H), 4.59 (s, 2H), 3.83 (bs, 
1H), 3.82 (s, 3H), 3.65 (t, J=3.5, 1H), 2.76 (dd, J1=3.5, J2=9.5, 1H), 2.35-2.37 (m, 
1H), 1.89 (t, J=14.5, 1H), 1.80 (dd, J1=4, J2=14.5, 1H), 1.48-1.70 (m, 1H), 1.00 (d, 
J=7.3, 3H). 
13C NMR (125 MHz, CDCl3)  162.8, 158.7, 155.0, 138.2, 132.7, 128.3, 127.6, 127.5, 120.9, 118.8, 85.8, 
81.3, 73.1, 70.0, 52.4, 44.7, 35.9, 26.5, 17.0. 
IR (film): cm-1 3460, 2924, 1819, 1730, 1115. 
HRMS (m/z) [M+H]+ calcd. for C21H25O6: 373.1646; found: 373.1635. 
[]D
20 +12.1 (c 0.1, CHCl3). 
Rf= 0.20 (petroleum ether : ethyl acetate = 2 : 1). 
 
2.33 (3R,4R,5R)-3-(benzyloxy)-2-ethylidene-4-hydroxy-5-methylcyclohexanone (45) 
 
 
Silver carbonate (6.1 mg; 0.022 mmol; 1 eq) was added to a solution of alkyne 42 (6.3 mg; 0.022 mmol) 
in dry benzene (600 L) and the suspension was stirred for 18 h at 80 °C. The black suspension was 
evaporated to dryness and the residue was purified by column chromatography (eluent: petroleum 
ether : ethyl acetate = 3 : 1), to give 1.2 mg (23%) of E-isomer of 45 and 1.0 mg (16%) of Z-isomer of 45. 
 
Spectral data for E-isomer 45 
1H NMR (500 MHz, CDCl3) 7.27-7.39 (m, 5H), 6.93 (q, J=7.0, 1H), 4.56 (d, J=4.0, 1H), 
4.54 (d, J=12.3, 1H), 4.38 (d, J=12.3, 1H), 4.06 (bs, 1H), 2.57-2.63 (m, 1H), 2.40 (dd, 
J1=4.5, J2=17.0, 1H), 2.30 (dd, J1=12.3, J2=4.5, 1H), 1.84 (d, J=7.5, 3H), 1.08 (d, J=7.0, 
3H). 
13C NMR (125 MHz, CDCl3)  200.7, 140.7, 138.0, 135.0, 128.4, 127.8, 127.5, 74.5, 71.5, 69.8, 42.1, 29.3, 
17.3, 13.9.
IR (film): cm-1 3442, 2928, 1690, 1258, 833. 
HRMS (m/z) [M+Na]+ calcd. for C16H20O3Na: 283.1305; found: 283.1298. 
[]D
20 +17.2 (c 0.1, CHCl3). 
Rf=0.23 (petroleum ether : ethyl acetate = 3 : 1). 
 
Spectral data for Z-isomer 45 
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1H NMR (500 MHz, CDCl3) 7.27-7.35 (m, 5H), 5.94 (q, J=7.0, 1H), 4.57 (d, J=12.1, 
1H), 4.29 (d, J=12.1, 1H), 4.00, (d, J=4.1, 1H), 3.95 (bs, 1H), 2.56-2.60 (m, 1H), 2.35-
2.37 (m, 2H), 1.99 (d, J=7.3, 3H), 1.60 (d, J=5.0, 1H), 1.07 (d, J=6.9, 3H). 
13C NMR (125 MHz, CDCl3) 202.5, 139.3, 137.8, 134.6, 128.3, 127.7, 127.6, 83.9, 
72.3, 69.1, 44.6, 30.8, 16.9, 15.2.
IR (film): cm-1 3444, 2932, 1686, 1257, 840. 
HRMS (m/z) [M+Na]+ calcd. for C16H20O3Na: 283.1305; found: 283.1302. 
[]D
20 +13.6 (c 0.1, CHCl3). 
Rf=0.14 (petroleum ether : ethyl acetate = 3 : 1). 
 
2.34 (1R,2S,3R,4R,5R)-3-(benzyloxy)-1-(bromoethynyl)-5-methyl-2-vinylcyclohexane-1,4-diol 
(46) 
 
 
A finely powdered silver nitrate (1.8 mg; 10.8 mol; 1 eq) was added to solution of alkyne 42 (3.1 mg; 
10.8 mol) in acetone (0.5 mL), and after 10 minutes the mixture was treated with a freshly 
recrystallized N-bromosuccinimide (1.8 mg; 10.8 mol; 1 eq). The mixture was stirred for 15 minutes at 
room temperature and evaporated to dryness. The crude product was purified by column 
chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1), to give 3.3 mg (85 %) of bromoalkyne 
46, as a colorless film. 
 
1H NMR (500 MHz, CDCl3)  7.26-7.37 (m, 5H), 6.22-6.30 (m, 1H), 5.27-5.31 (m, 2H), 4.58 (ABq, J=10.2, 
2H), 4.30 (s, 1H), 3.84 (bs, 1H), 3.77 (t, J=3.4, 1H), 2.65 (dd, J1=2.6, J2=8.6, 1H), 2.17-2.25 (m, 1H), 1.91 
(dd, J1=4.1, J2=13.8, 1H), 1.80 (t, J=13.8, 1H), 1.48 (d, J=3.1, 1H), 1.00 (d, J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  137.1, 134.7, 128.5, 128.2, 127.7, 118.6, 83.0, 82.7, 73.9, 71.7, 69.7, 46.4, 
43.7, 41.5, 25.6, 16.7. 
IR (film): cm-1 3442, 2924, 1407, 1063, 994. 
HRMS (m/z) [M+Na]+ calcd. for C18H21BrO3Na: 387.0566; found: 387.0583. 
[]D
20 +43.0 (c 0.3, CHCl3). 
Rf=0.67 (petroleum ether : ethyl acetate = 2 : 1). 
 
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry
This journal is © The Royal Society of Chemistry 2013
S33 
 
2.35 Ethyl 3-(1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-hydroxy-5-
methyl-2-vinylcyclohexyl)propiolate (48) and (1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-
butyldimethylsilyloxy)-5-methyl-1-(3,3,3-triethoxyprop-1-ynyl)-2-vinylcyclohexanol (50) 
 
A) Reaction with 3,3,3‐triethoxyprop‐1‐yne: n‐Butyl lithium (1.5 M in hexanes; 4.1 mL; 6.12 mmol; 3.5 
eq) was added to the cold (‐30 °C) solution of diisopropylamine (865 μL; 6.12 mmol; 3.5 eq) in dry 
toluene (30 mL). After 30 minutes of stirring, the resulting solution of LDA was cooled to ‐78 °C and 
3,3,3‐triethoxyprop‐1‐yn (1.204 g; 6.99 mmol; 4 eq) was added dropwise. The stirring was continued for 
additional 30 minutes and the solution of (2S,3R,4R,5R)‐3‐(benzyloxy)‐4‐(tert-butyldimethylsilyloxy)‐5‐
methyl‐2‐vinylcyclohexanone 37 (655 mg; 1.748 mmol) in dry toluene (60 mL) was added dropwise. 
After 20 minutes the reaction was allowed to warm up to 0 °C during one hour and the reaction was 
quenched with brine (20 mL). The product was extracted with ethyl acetate, the organic layer dried over 
MgSO4 and concentrated under reduced pressure. The crude product was purified by dry flash 
chromatography (gradient elution: petroleum ether : ethyl acetate, from 95 : 2 to 9 : 1), to give 782 mg 
of the mixture of compounds 48 and 50, which was used as such in the following transformation (i. e. 
experiment 2.36). 
B) Reaction with ethyl propiolate: n‐Butyl lithium (1.36 M in hexanes; 28 L; 1.5 eq) was added to the 
cold (‐78 °C) solution of ethyl propiolate (3.4 μL; 0.033 mmol; 1.3 eq) in dry THF (0.8 mL). After 60 
minutes of stirring, a solution of ketone 37 (9.6 mg; 0.026 mmol) in dry THF (0.2 mL) was added 
dropwise. The mixture was allowed to reach room temperature during 60 minutes and the reaction was 
quenched by the addition of saturated ammonium chloride solution. The mixture was extracted with 
ethyl acetate, washed with brine, dried over MgSO4 and concentrated under reduced pressure. The 
crude product was purified by column chromatography (eluent: petroleum ether : ethyl acetate = 9 : 1), 
to give 4 mg (33%) of the product 48, as a colorless oil. 
 
Spectral data for 48 
1H NMR (500 MHz, CDCl3)  7.27-7.36 (m, 5H), 6.22-6.29 (m, 1H), 5.25-5.31 (m, 2H), 4.57 (d, J=1.5, 2H), 
4.44 (s, 1H), 4.20 (q, J=7.5, 2H), 3.70 (t, J=3, 1H), 3.60 (t, J=3, 1H), 2.66 (dd, J1=2, J2=8.5, 1H), 2.15-2.18 
(m, 1H), 1.78-1.88 (m, 2H), 1.28 (t, J=7.5, 3H), 0.91 (d, J=7, 3H), 0.88 (s, 9H), 0.01 (s, 3H), -0.04 (s, 3H). 
13C NMR (125 MHz, CDCl3)  153.7, 137.0, 134.6, 128.6, 128.3, 127.9, 118.7, 89.4, 83.6, 75.2, 74.0, 70.8, 
70.4, 61.9, 46.0, 41.0, 25.8, 18.0, 17.4, 14.0, -4.7, -4.9. 
IR (film): cm-1 3474, 2955, 2930, 1712, 1247, 1062. 
HRMS (m/z) [M+NH4]
+ calcd. for C27H44NO5Si: 490.2983; found: 490.2976. 
[]D
20 +13.0 (c 1.0, CHCl3). 
Rf=0.27 (petroleum ether : ethyl acetate = 9 : 1). 
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2.36 Ethyl 3-(1R,2S,3R,4R,5R)-3-(benzyloxy)-1,4-dihydroxy-5-methyl-2-
vinylcyclohexyl)propiolate (51) 
 
 
The mixture of propiolate 48 and the corresponding orthoester 50 (782 mg), from the previous step, was 
dissolved in acetonitrile (5 mL) in a polyethylene flask, and 50% hydrofluoric acid (2.1 mL) was added 
dropwise to the solution. The mixture was stirred at 60 °C for 9 h, and then partitioned between ethyl 
acetate and saturated sodium bicarbonate solution. The organic extract was washed with brine, dried 
over MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (eluent: petroleum ether : ethyl acetate = 5 : 2) to give 473 mg (75% from 37) of diol 
51, as a colorless solid. 
 
mp 80 °C 
1H NMR (500 MHz, CDCl3) 7.27-7.34 (m, 5H), 6.19-6.27 (ddd, J1=1.5, J2= 8.5, J3=10.1, 1H), 5.30-5.34 (m, 
2H), 4.61 (d, J=11.5, 1H), 4.55 (d, J=11.5, 1H), 4.39 (s, 1H), 4.19 (q, J=7.5, 
2H), 3.86 (bs, 1H), 3.78 (t, J=2.9, 1H), 2.72 (dd, J=2.5, J=9.2, 1H), 2.19-2.25 
(m, 1H), 1.93 (dd, J=4.1, J=13.5, 1H), 1.85 (t, J=13.5, 1H), 1.73 (bs, 1H), 1.28 
(t, J=7.5, 3H), 1.00 (d, J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  153.6, 137.0, 134.1, 128.5, 128.2, 127.7, 119.1, 
89.2, 82.9, 75.3, 74.0, 70.8, 69.5, 61.9, 45.8, 40.7, 25.4, 16.7, 13.9. 
IR (film): cm-1 3453, 2961, 2238, 1710, 1248, 1068, 1028. 
HRMS (m/z) [M+NH4]
+ calcd. for C21H30NO5: 376.2118; found: 376.2119. 
Elemental analysis: calcd. for C21H26O5: C 70.37%, H 7.31%; found: C 70.67%, H 7.48%. 
[]D
20 +49.8 (c 0.4, EtOAc). 
Rf=0.39 (petroleum ether : ethyl acetate = 2 : 1). 
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2.37 (Z)-ethyl 2-((1R,4R,5S,6R,7R)-6-(benzyloxy)-4-hydroxy-7-methyl-5-vinyl-2-
oxabicyclo[2.2.2]octan-3-ylidene)acetate (Z-63) 
 
 
A) Reaction in methanol as a solvent: A solution of (triphenylphosphine)gold(I)bis(trifluoromethane 
sulfonyl) imidate (1.1 mg; 10 mol%) and ethyl 3‐((1R,2S,3R,4R,5R)‐3‐(benzyloxy)‐1,4‐dihydroxy‐5‐ 
methyl‐2‐vinylcyclohexyl)propiolate 51 (5.2 mg; 14.5 μmol) in dry methanol (1 mL) was stirred for 4 h at 
60 °C. Methanol was removed on rotovap and the residue was purified by column chromatography 
(gradient elution: petroleum ether : ethyl acetate, from 3 : 1 to 1 : 1), affording 1.1 mg (21%) of methyl 
tetronate 60, followed by an inseparable mixture (3.1 mg) of 61 (7%), 62 (14%) and Z-63 (38%). 
B) Reaction in 2-propanol as a solvent: A solution of (triphenylphosphine)gold(I) 
bis(trifluoromethanesulfonyl)imidate (2.1 mg; 10 mol%) and ethyl 3‐((1R,2S,3R,4R,5R)‐3‐(benzyloxy)‐ 
1,4‐dihydroxy‐5‐methyl‐2‐vinylcyclohexyl)propiolate 51 (10 mg; 27.9 μmol) in dry 2-propanol (1 mL) was 
stirred for 1.5 h at 70 °C. 2-Propanol was removed on rotovap and the residue was purified by column 
chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1), affording 8.5 mg (85%) of an 
inseparable mixture of 62 (25%) and Z-63 (60%). 
 
Spectral data for compound (extracted from NMR spectrum of the mixture produced by protocol A) 61 
1H NMR (500 MHz, CDCl3)  7.27-7.36 (m, 5H), 6.01-6.09 (m, 1H), 5.67 (s, 1H), 5.12-5.17 (m, 2H), 4.62 (d, 
J=11.0, 1H), 4.55 (d, J=11.0, 1H), 4.09-4.17 (m, 2H), 3.92 (s, 3H), 3.88 (bs, 1H), 3.81 (t, J=3.2, 1H), 2.88 
(dd, J1=2.6, J2=9.1, 1H), 2.20-2.30 (m, 1H), 1.93 (t, J=13.1, 1H), 1.37 (dd, J1=3.7, J2=13.1, 1H), 1.25 (t, 
J=7.1, 3H), 1.00 (d, J=7.0, 3H). 
HRMS (m/z) [M+H]+ calcd. for C22H31O6: 391.2115; found: 391.2115. 
 
Spectral data for -ketoester 62 
1H NMR (500 MHz, CDCl3)  7.28-7.36 (m, 5H), 6.06 (dt, J1=9.8, J2=19.6, 1H), 5.11-5.17 (m, 2H), 4.62 (d, 
J=11.6, 1H), 4.53 (d, J=11.6, 1H), 4.45 (s, 1H), 4.13-4.19 (m, 2H), 3.9 (bs, 1H), 3.75 (t, J=3.2, 1H), 3.70 (d, 
J=16.4, 1H), 3.38 (d, J=16.4, 1H), 2.84 (dd, J1=2.4, J2=9.5, 1H), 2.21-2.24 (m, 1H), 1.79 (t, J=13.5, 1H), 1.52-
1.55 (m, 1H), 1.20-1.28 (m, 1H), 1.25 (t, J=7.2, 3H), 1.01 (d, J=6.9, 3H). 
13C NMR (125 MHz, CDCl3)  207.9, 167.9, 137.1, 133.6, 128.6. 128.2, 127.8, 119.5, 83.3, 82.9, 73.9, 69.6, 
61.0, 46.3, 44.2, 37.0, 25.5, 17.0, 14.1. 
IR (film): cm-1 3474, 2959, 2922, 1741, 1712, 1313, 1256, 1088, 1063, 1030. 
HRMS (m/z) [M+K]+ calcd. for C21H28O6K: 415.1517; found: 415.1518. 
[]D
20 +53.0 (c 0.2, CHCl3). 
Rf= 0.26 (petroleum ether : ethyl acetate = 3 : 1). 
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Spectral data for bicyclic ether Z-63 
1H NMR (500 MHz, CDCl3)  7.26-7.36 (m, 5H), 6.11 (dt, J1=10.2, J2=17.0, 1H), 5.44 
(dd, J1=1.9, J2=10.1, 1H), 5.33 (dd, J1=1.9, J2=17.0, 1H), 5.27 (s, 1H), 4.60 (d, J=12.0, 
1H), 4.42 (d, J=12.0, 1H), 4.23 (dd, J1=1.0, J2=4.1, 1H), 4.09-4.18 (m, 2H), 4.07 (dd, 
J1=4.1, J2=9.8, 1H), 2.58 (dt, J1=1,8, J2=9.9, 1H), 2.50-2.57 (m, 1H), 2.19 (dd, J1=11.1, 
J2=12.9, 1H), 1.94 (bs, 1H), 1.25 (t, J=7.1, 3H), 1.11 (ddd, J1=2.1, J2=4.9, J3=12.9, 1H), 
1.08 (J=6.7, 3H). 
13C NMR (125 MHz, CDCl3)  172.8, 165.9, 137.6, 131.9, 128.4, 127.9, 127.5, 122.4, 86.8, 76.9, 73.6, 72.4, 
69.9, 59.1, 49.2, 35.7, 26.1, 19.4, 14.4. 
HRMS (m/z) [M+H]+ calcd. for C21H28O5: 359.1858; found: 359.1860. 
IR (film): cm-1 3426, 2966, 2928, 1692, 1643, 1185, 1080, 999. 
[]D
20 +28.0 (c 0.1, CHCl3). 
Rf=0.34 (petroleum ether : ethyl acetate = 3 : 1). 
 
2.38 (E)-ethyl 2-((1R,4R,5S,6R,7R)-6-(benzyloxy)-4-hydroxy-7-methyl-5-vinyl-2-
oxabicyclo[2.2.2]octan-3-ylidene)acetate (E-63) 
 
A quartz test tube, containing a solution of bicyclic enolether Z-63 (3.5 mg; 9.8 mol) in dry n-hexane (3 
mL), was irradiated with UV light from a low pressure mercury lamp (6W), under an argon atmosphere. 
After 6 minutes of the irradiation, a photochemical equilibrium was reached and the mixture was 
evaporated to dryness. The significantly less polar E-isomer (1.0 mg) was separated from the Z-isomer 
(2.2 mg) by column chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1). The isolated 
starting material was subjected to the second photochemical cycle, to afford additional 0.7 mg of E-
isomer. The overall yield of E-63 was 50% (71% based on the recovered starting material).  
 
1H NMR (500 MHz, CDCl3)  7.95 (s, 1H), 7.27-7.36 (m, 5H), 6.05 (dt, J1=10.1, J2=17.0, 1H), 5.39 (dd, 
J1=2.0, J2=10.1, 1H), 5.35 (ddd, J1=0.6, J2=2.1, J3=17.0, 1H), 5.32 (s, 1H), 4.65 (d, J=11.7, 1H), 4.39 (d, 
J=11.7, 1H), 4.14 (q, J=7.1, 2H), 4.02 (dd, J1=0.6, J2=3.9, 1H), 3.88 (dd, J1=3.8, J2=9.6, 1H), 2.76 (dt, J1=1.8, 
J2=9.8, 1H), 2.46-2.55 (m, 1H), 2.35 (dd, J1=10.9, J2=13.2, 1H), 1.27 (t, J=7.1, 3H), 1.21 (ddd, J1=1.7, J2=5.6, 
J3=13.2, 1H), 1.04 (d, J=7.2, 3H). 
13C NMR (125 MHz, CDCl3)  179.9, 170.4, 137.8, 131.6, 128.4, 127.8, 127.6, 121.3, 92.9, 77.7, 74.0, 
72.5, 72.3, 60.9, 49.7, 36.1, 22.6, 19.5, 14.2. 
IR (film): cm-1 3421, 2967, 2942, 1652, 1082. 
HRMS (m/z) [M+Na]+ calcd. for C21H28O6Na: 381.1672; found: 381.1669. 
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[]D
20 +21.5 (c 0.1, CHCl3). 
Rf=0.76 (petroleum ether : ethyl acetate = 2 : 1). 
 
2.39 (5R,6R,7aR,8S,9R)-8-vinyl-6,7-dihydro-9-(benzyloxy)-6-methyl-5H-5,7a-ethano-2H-
furo[3,2-b]pyran-2-one (47) 
 
A) Base promoted cyclization of E-63: A catalytic amount of sodium hydride was added to a solution of 
bicyclic enolether E-63 (1.4 mg; 3.9 mol) in dry THF (0.5 mL), under an argon atmosphere. The reaction 
mixture was stirred for 30 minutes at room temperature, diluted with diethyl ether and the organic 
layer was washed with brine. The organic extract was dried over anhydrous MgSO4, evaporated under 
reduced pressure and purified by column chromatography (eluent: petroleum ether : ethyl acetate = 3 : 
1), to afford 1.2 mg (85%) of the pure product 47, as a white solid. 
 
B) Three step one-pot sequence: A solution of (triphenylphosphine)gold(I)-bis(trifluoromethanesulfonyl) 
imidate (10mg; 10 mol%) and ethyl 3‐((1R,2S,3R,4R,5R)‐3‐(benzyloxy)‐1,4‐dihydroxy‐5‐methyl‐2‐
vinylcyclohexyl)propiolate 51 (50 mg; 0.14 mmol) in dry 2‐propanol (5 mL) was heated at 70 °C, under an 
argon atmosphere. After 150 minutes TLC indicated the complete conversion of the starting material to 
a single intermediate (bicyclic Z‐enolether Z-63). The yellowish‐brown solution was transferred to the 
quartz test tube, diluted with 2‐propanol (4.5 mL), the solution of sodium 2‐propoxide (prepared from 
0.7 mg of sodium hydride and 0.5 mL of 2‐propanol; 20 mol%) was added, and the reaction mixture 
irradiated with UV light from a low pressure mercury lamp (6W). After two hours of irradiation, the 
mixture was concentrated to 2 mL and partitioned between ethyl acetate and brine, the organic layer 
was dried over MgSO4, and concentrated under reduced pressure. The residue was purified by column 
chromatography (eluent: petroleum ether : ethyl acetate = 4 : 1) to afford 26.2 mg (60%) of product 47, 
as a colorless oil. 
 
1H NMR (500 MHz, CDCl3) 7.28-7.39 (m, 5H), 6.07-6.14 (m, 1H), 5.38-5.42 (m, 2H), 4.94 (s, 1H), 4.65 (d, 
J=11.5, 1H), 4.42 (d, J=11.5, 1H), 4.28 (dd, J1=1.5, J2=3.4, 1H), 4.03 (dd, J1=3.4, J2=9.5, 1H), 2.74 (dd, 
J1=11.1, J2=12.5, 1H), 2.59-2.64 (m, 2H), 1.10 (d, J=7.5, 3H), 1.00 (ddd, J1=2.5, J2=5.2, J3=7.1, 1H). 
13C NMR (125 MHz, CDCl3) 183.8, 172.8, 137.1, 129.6, 128.5, 128.1, 127.6, 122.2, 84.6, 80.7, 79.3, 73.1, 
72.8, 46.0, 31.7, 25.4, 19.1. 
IR (film): cm-1 2967, 1765, 1650, 1083, 912. 
HRMS (m/z) [M+H]+ calcd. for C19H21O4: 313.1434; found: 313.1430. 
Elemental analysis: calcd. for C19H20O4: C 73.06%, H 6.45%; found: C 72.65%, H 6.72%. 
[]D
20 +11.1 (c 1.0, EtOAc). 
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Rf=0.42 (petroleum ether : ethyl acetate = 3 : 1). 
 
2.40 (4R,5R)-4-(tert-butyldimethylsilyloxy)-5-methyl-2-vinylcyclohex-2-enone (49) 
 
n‐Butyl lithium (1.5 M in hexanes; 50 L; 0.08 mmol; 3 eq) was added dropwise to a cold (‐90 °C) 
solution of ethyl propiolate (8.1 L; 0.08 mmol; 3 eq) in dry THF (0.5 mL). After 15 minutes, HMPA (37 
L; 0.214 mmol; 6 eq) was added and stirring was continued for additional 15 minutes. A solution of 
ketone 37 (10 mg; 0.0267 mmol) in dry THF (0.2 mL) was added to the resulting mixture, which was 
allowed to reach -60 °C over 1 h. The reaction was quenched by the addition of saturated ammonium 
chloride (1 mL) and the product was extracted with dichloromethane. The organic extract was washed 
with brine, dried over MgSO4 and concentrated under reduced pressure. Purification of the residue by 
column chromatography (eluent: petroleum ether : ethyl acetate = 95 : 5) gave 3.7 mg (52%) of diene 
49, as a colorless film. 
 
1H NMR (200 MHz, CDCl3)  6.77 (d, J=3.8, 1H), 6.55 (dd, J1=11.2, J2=17.4, 1H), 5.73 (d, J=17.4), 5.26 (d, 
J=11.2, 1H), 4.51 (t, J=4.0, 1H), 2.31-2.65 (m, 3H), 1.04 (d, J=6.8, 3H), 0.95 (s, 9H), 0.15 (s, 6H). 
HRMS (m/z) [M+H]+ calcd. for C15H27O2Si: 267.1775; found: 267.1778. 
Rf=0.48 (petroleum ether : ethyl acetate = 95 : 5). 
 
2.41  (Z)-methyl 3-((1R,2S,3R,4R,5R)-3-(benzyloxy)-4-(tert-butyldimethylsilyloxy)-1-hydroxy-
5-methyl-2-vinylcyclohexyl)-3-methoxyacrylate (52) and (5R,6S,7R,8R,9R)-7-
(benzyloxy)-8-(tert-butyldimethylsilyloxy)-4-methoxy-9-methyl-6-vinyl-1-
oxaspiro[4.5]dec-3-en-2-one (53) 
 
A) Magnesium methoxide catalyzed cyclization of 48: Methanolic solution of magnesium methoxide 
(100 L; 8.6 mol; 2 eq) was added to a solution of propiolate 48 (2.7 mg; 5.7 mol) in dry methanol 
(100 L), under an argon atmosphere. The solution was stirred for 4 h at 55 °C, evaporated to dryness 
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry
This journal is © The Royal Society of Chemistry 2013
S39 
 
and purified by column chromatography (gradient elution from petroleum ether : ethyl acetate = 95 : 5 
to 8 : 2), to give 1.0 mg (36%) of product 52 and 0.8 mg (29%) of methyl tetronate 53, as a colorless oils. 
B) Cyclization of 50 catalyzed by mercury modified nafion resin: Finely powdered nafion resin modified 
with mercury (22.6 mg) was added to a solution of 50 (104 mg; 0.19 mmol) in methanol (6.3 mL) and 
water (17 μL; 0.95 mmol; 5 eq). After 2 days of stirring at room temperature, the resin was removed by 
filtration and the solution was evaporated to dryness. Purification of the residue by column 
chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1) afforded 78 mg (90%) of tetronate 53, 
as a colorless oil. 
 
Spectral data for compound 52 
1H NMR (500 MHz, CDCl3)  7.27-7.37 (m, 5H), 6.02-6.09 (m, 1H), 5.70 (s, 1H), 5.07-5.13 (m, 2H), 4.56 (s, 
2H), 4.46 (s, 1H), 3.90 (s, 3H), 3.71 (t, J=2.4, 1H), 3.66 (s, 3H), 3.60 (t, J=3.1, 1H), 2.95 (dd, J1=2.6, J2=9.2, 
1H), 2.12-2.21 (m, 1H), 1.99 (t, J=12.8, 1H), 1.28 (dd, J1=3.9, J2=12.8, 1H), 0.90 (s, 9H), 0.90 (d, J=7.6, 3H), 
0.01 (s, 3H), -0.04 (s, 3H). 
HRMS (m/z) [M+H]+ calcd. for C27H43O6Si: 491.2823; found: 491.2227. 
Rf=0.75 (petroleum ether : ethyl acetate = 3 : 1). 
 
Spectral data for methyl tetronate 53 
1H NMR (500 MHz, CDCl3)  7.27-7.37 (m, 5H), 6.02-6.09 (m, 1H), 5.70 (s, 1H), 5.07-5.13 (m, 2H), 4.56 (s, 
2H), 4.46 (s, 1H), 3.90 (s, 3H), 3.71 (t, J=2.4, 1H), 3.66 (s, 3H), 3.60 (t, J=3.1, 1H), 2.95 (dd, J1=2.6, J2=9.2, 
1H), 2.12-2.21 (m, 1H), 1.99 (t, J=12.8, 1H), 1.28 (dd, J1=3.9, J2=12.8, 1H), 0.90 (s, 9H), 0.90 (d, J=7.6, 3H), 
0.01 (s, 3H), -0.04 (s, 3H). 
13C NMR (125 MHz, CDCl3)  184.3, 172.4, 138.7, 134.0, 128.2, 127.5, 127.4, 118.1, 88.7, 85.5, 81.3, 73.1, 
71.0, 59.2, 43.3, 34.9, 26.8, 25.7, 18.0, 17.7, -4.7, -5.0. 
IR (film): cm-1 2954, 2930, 1756, 1637, 1065. 
HRMS (m/z) [M+H]+ calcd. for C26H39O5Si: 459.2567; found: 459.2576. 
[]D
20 -13.4 (c 1.0, CHCl3). 
Rf=0.44 (petroleum ether : ethyl acetate = 2 : 1). 
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2.42 (Z)-ethyl 3-((1R,2S,3R,4R,5R)-3-(benzyloxy)-1,4-dihydroxy-5-methyl-2-vinylcyclohexyl)-
3-ethoxyacrylate (54) and (5R,6S,7R,8R,9R)-7-(benzyloxy)-4-ethoxy-8-hydroxy-9-
methyl-6-vinyl-1-oxaspiro[4.5]dec-3-en-2-one (55) 
 
A) Base promoted cyclization of compound 51: A solution (THF) of bromomagnesium diisopropylamide 
(c=0.3 mM; 190 L; 0.056 mmol; 10 eq) was added to a solution of compound 51 (2 mg; 5.6 mol) in dry 
THF (150 L), under an argon atmosphere. The mixture was heated for 3 h at 55 °C and then evaporated 
to dryness. The product was purified by column chromatography (eluent: petroleum ether : ethyl 
acetate = 2:1), to give 0.6 mg (36%) of product 54 and 0.4 mg (29%) of methyl tetronate 55, as colorless 
oils. 
 
B) Compound 55 (deprotection of TBDMS-ether 56): A solution of silyl ether 56 (30 mg; 0.0635 mmol) in 
acetonitrile (1 mL) and 50% hydrofluoric acid (250 L) was heated to 40 °C over 7 days, in a polyethylene 
flask. The reaction mixture was diluted with ethyl acetate and washed with saturated sodium 
bicarbonate and brine. The organic layer was dried over anhydrous MgSO4, evaporated under reduced 
pressure and purified by dry flash chromatography (eluent: petroleum ether : ethyl acetate = 1 : 1), to 
give 20.6 mg (91%) of the pure product 55, as a white solid. 
 
Spectral data for compound 54 
1H NMR (500 MHz, CDCl3) 7.27-7.36 (m, 5H), 6.01-6.08 (m, 1H), 4.93-5.09 (m, 2H), 5.66 (s, 1H), 5.13-
5.18 (m, 2H), 4.62 (d, J=11.5, 1H), 4.55 (d, J=11.5, 1H), 4.52 (s, 1H), 4.41 (dq, J1=7.8, J2=11.0, 1H), 4.05-
4.15 (m, 2H), 3.99 (dq, J1=7.8, J2=11.0, 1H), 3.88 (bs, 1H), 3.81 (t, J=3.3, 1H), 2.90 (dd, J1=2.6, J2=8.6, 1H), 
2.22-2.30 (m, 1H), 1.97 (t, J=15.4, 1H), 1.38 (dd, J1=3.7, J2=15.4, 1H), 1.28 (t, J=7.5, 3H), 7.4, (t, J=7.5, 3H), 
1.01 (d, J=7.0, 3H). 
HRMS (m/z) [M+Na]+ calcd. for C23H32O6Na: 427.2091; found: 427.2088. 
 
Spectral data for compound 55 
mp 178 °C 
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1H NMR (500 MHz, CDCl3) 7.23-7.37 (m, 5H), 5.89 (dt, J1=9.5, J2=17.5, 1H), 4.93-5.09 (m, 2H), 4.58 (s, 
1H), 4.58 (ABq, J=2.0, 2H), 3.92-4.07 (m, 2H), 3.82 (bs, 1H), 3.61 (bs, 1H), 2.77 (dd, J1=3.1, J2=9.4, 1H), 
2.41-2.51 (m, 1H), 1.96 (t, J=13.3, 1H), 1.76 (bs, 1H), 1.37 (t, J=6.8, 3H), 1.34-1.38 (m, 1H), 0.97 (d, J=7.0 
3H). 
13C NMR (125 MHz, CDCl3)  183.2, 172.7, 138.7, 133.6, 128.2, 127.3, 127.2, 118.5, 88.6, 85.3, 81.1, 73.0, 
70.3, 68.3, 43.3, 34.7, 26.5, 17.2, 14.0. 
IR (film): cm-1 3538, 2923, 1727, 1626, 1324, 1201, 1033, 802. 
HRMS (m/z) [M+NH4]
+ calcd. for C21H30NO5: 376.2118; found: 376.2115. 
[]D
20 +10.5 (c 0.2, CHCl3). 
Rf=0.38 (petroleum ether : ethyl acetate = 1 : 1). 
 
2.43 (5R,6S,7R,8R,9R)-7-(benzyloxy)-8-(tert-butyldimethylsilyloxy)-4-ethoxy-9-methyl-6-
vinyl-1-oxaspiro[4.5]dec-3-en-2-one (56) 
 
Finely powdered nafion resin modified with mercury (20 mg) was added to a solution of 50 (44 mg; 0.08 
mmol) in dry ethanol (2.5 mL) and water (7.2 μL; 0.40 mmol; 5 eq). After 2 days of stirring at room 
temperature, the resin was removed by filtration and the solution evaporated to dryness. Purification of 
the residue by column chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1) afforded 31 mg 
(82%) of tetronate 56, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.31-7.37 (m, 5H), 5.90 (dt, J1=10.0, J2=17.5, 1H), 4.98-5.04 (m, 2H), 4.92 (s, 
1H), 4.61 (d, J=12.5, 1H), 4.52 (d, J=12.5, 1H), 4.03 (dq, J1=7.1, J2=9.8, 1H), 3.94 (dq, J1=7.1, J2=9.8, 1H), 
3.65 (bs, 1H), 3.43 (t, J=3.5, 1H), 2.77 (dd, J1=3.5, J2=9.5, 1H), 2.39-2.41 (m, 1H), 1.97 (t, J=13.5, 1H), 1.37 
(t, J=7.1, 3H), 1.29 (dd, J1=3.5, J2=13.5, 1H), 0.89 (s, 9H), 0.87 (d, J=6.5, 3H), -0.02 (s, 3H), -0.07 (s, 3H).  
13C NMR (125 MHz, CDCl3)  183.3, 172.8, 138.7, 134.0, 128.2, 127.5, 127.4, 118.1, 89.5, 85.4, 81.3, 73.1, 
71.0, 68.1, 43.3, 35.0, 26.7, 25.6, 17.9, 17.8, 13.9, -4.7, -5.0. 
IR (film): cm-1 2955, 2930, 2857, 1757, 1634, 1067. 
HRMS (m/z) [M+Na]+ calcd. for C27H40O5Na: 495.2537; found: 495.2524. 
[]D
20 -6.3 (c 0.2, CHCl3). 
Rf=0.30 (petroleum ether : ethyl acetate = 3 : 1). 
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2.44 Ethyl 2-((1R,3S,4R,5R,6R)-4-(benzyloxy)-6-methyl-2-oxo-3-vinyl-8-
oxabicyclo[3.2.1]octan-1-yl)acetate (58) 
 
A solution of (triphenylphosphine)gold(I) bis(trifluoromethanesulfonyl)imidate (0.7 mg; 10 mol%) and 
ethyl 3‐((1R,2S,3R,4R,5R)‐3‐(benzyloxy)‐1,4‐dihydroxy‐5‐methyl‐2‐vinylcyclohexyl)propiolate 51 (3.5 mg; 
7 μmol) in dichloromethane (1.5 mL) was heated overnight to 120 °C in a sealed ampoule. After cooling 
to room temperature, the solvent was removed on rotovap. Purification of the residue by column 
chromatography (petroleum ether : ethyl acetate = 4 : 1), afforded 2.7 mg (77%) of the title compound 
58, as a colorless oil. 
 
1H NMR (500 MHz, CDCl3)  7.27-7.36 (m, 5H), 5.67 (dt, J1=10.0, J2=17.0, 1H), 5.23-5.28 (m, 2H), 4.65 (d, 
J=12.2, 1H), 4.45 (d, J=12.2, 1H), 4.37 (dd, J1=6.8, J2=8.8, 1H), 4.31 (d, J=6.8, 1H), 4.11-4.16 (m, 2H), 3.05 
(d, J=16.2, 1H), 2.96 (t, J=9.5, 1H), 2.78 (dd, J1=8.1, J2= 17.5, 1H), 2.56-2.62 (m, 1H), 2.46 (d, J=16.2, 1H), 
2.25 (ddd, J1=1.5, J2=3.2, J3=17.5, 1H), 1.24 (s, 9H) 1.23 (t, J=9.5, 3H). 
13C NMR (125 MHz, CDCl3)  207.8, 169.9, 137.8, 130.5, 128.4, 127.7, 127.2, 120.8, 88.1, 81.8, 79.4, 73.2, 
60.6, 54.5, 42.6, 37.7, 28.9, 20.8, 14.1. 
HRMS (m/z) [M+K]+ calcd. for C21H26KO5: 397.1412; found: 397.1404. 
IR (film): cm-1 2962, 2931, 1721, 1116, 1027. 
[]D
20 +46.0 (c 0.2, CHCl3). 
Rf=0.45 (petroleum ether : ethyl acetate =  3 : 1). 
 
2.45 (5R,6S,7R,8R,9R)-7-(Benzyloxy)-8-hydroxy-4-methoxy-9-methyl-6-vinyl-1-
oxaspiro[4.5]dec-3-en-2-one (60) 
 
A solution of silyl ether 53 (110 mg; 0.24 mmol) in acetonitrile (4 mL) and 50% hydrofluoric acid (1 mL) 
was heated to 50 °C over 55 h, in a polyethylene flask. The reaction mixture was diluted with ethyl 
acetate and washed with saturated sodium bicarbonate and brine. The organic layer was dried over 
anhydrous MgSO4, evaporated under reduced pressure and purified by dry flash chromatography 
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry
This journal is © The Royal Society of Chemistry 2013
S43 
 
(eluent: petroleum ether : ethyl acetate = 1 : 1), to afford 69 mg (84%) of the pure product 60, as a white 
solid. 
 
mp 164 °C 
1H NMR (500 MHz, CDCl3) 7.31‐7.37 (m, 4H), 7.23‐7.27 (m, 1H), 5.89 (ddd, J1=0.5, J2=9.5, J3=20, 1H), 
5.03‐5.09 (m, 2H), 4.97 (s, 1H), 4.58 (d, J=1, 2H), 3.82 (bs, 1H), 3.80 (s, 3H), 3.61 (t, J=3.5, 1H), 2.76 (dd, 
J1=3.5, J2=9.5, 1H), 2.42‐2.50 (m, 1H), 1.96 (t, J=13.5, 1H), 1.68 (bs, 1H), 1.37 (dd, J1=3.0, J2=13.5, 1H), 
0.97 (d, J=7.0, 3H). 
13C NMR (125 MHz, CDCl3)  184.2, 172.4, 138.6, 133.6, 128.2, 127.3, 127.2, 118.5, 88.8, 85.3, 80.9, 73.0, 
70.3, 59.1, 43.2, 34.7, 26.5, 17.2. 
IR (film): cm-1 3445, 2875, 1728, 1632, 1356, 1204, 954. 
HRMS (m/z) [M+NH4]
+ calcd. for C20H28NO5: 362.1962; found: 362.1958. 
[]D
20 +20.8 (c 0.59, ethyl acetate). 
Rf=0.31 (petroleum ether : ethyl acetate = 1 : 1). 
 
2.46 (5R,6R,7aS,8R,9R)-9-benzyloxy-3-[(2R,4S)-5-(tert-butyldimethylsilyloxy)-1-
(methoxymethoxy)-2,4-dimethylpentyl]-6,7-dihydro-9-methyl-7-vinyl-5H-5,7a-ethano-
2H-furo[3.2-b]pyran-2-one (65) 
 
tert‐Butyl lithium solution (0.4 mL; 1.5 M in pentane; 0.6 mmol; 1.3 eq) was added dropwise to a cold (‐
78 °C) solution of compound 47 (145 mg; 0.464 mmol) and a small crystal of 2,2’‐bipyridine in dry 
tetrahydrofuran (10 mL), under an argon atmosphere. The red reaction mixture was stirred at that 
temperature for 45 minutes, and the solution of (2R,4S)‐5‐(tert-butyldimethylsilyloxy)‐2,4‐dimethyl- 
pentanal 64 (170 mg; 0.696 mmol; 1.5 eq) in dry THF (3.5 mL) was added dropwise to the mixture. 
Stirring was continued for 10 minutes at ‐78 °C and then for 40 minutes at ‐40 °C, before 
methoxymethylbromide (76 μL; 0.928 mmol; 1.5 eq) was added to the reaction mixture and the 
temperature was allowed to reach ‐25 °C. The reaction mixture was stirred for one hour at that 
temperature, then quenched by the addition of water (5 mL), the product was extracted with ethyl 
acetate, the organic layer was washed with brine, dried over MgSO4 and concentrated under reduced 
pressure. Purification of the residue by column chromatography (eluent: petroleum ether : ethyl acetate 
= 5 : 1) afforded 125 mg (44%; mixture of 2 inseparable isomers in a ratio 1 : 1.8) of compound 65, as a 
colorless oil, followed by 64.2 mg of the unreacted starting compound 47 (the yield calculated on the 
basis on the recovered starting material 47 was 79%). 
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Spectral data for the mixture of diastereoisomers (assignation of peaks in 1H NMR and 13C NMR spectra 
is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.25-7.40 (m, 5H), 6.05-6.14 (m, 1H), 5.36-5.43 (m, 2H), 4.65 (d, J=11.7, 1H), 
4.59 (d, J=6.7, 1H), 4.56 (d, J=6.7, 1H), 4.41 (d, J=11.7, 1H), 4.29-4.31 (m, 1H), 4.27 (d, J=5.5, 1H), 3.97 
(dd, J1=3.6, J2=9.7, 1H), 3.51 (dd, J1=5.2, J2=9.8, 1H), 3.34 (s, 3H), 3.27 (dd, J1=7.2, J2=9.8, 1H), 2.72-2.80 
(m, 1H), 2.52-2.64 (m, 2H), 1.98-2.07 (m, 1H), 1.65-1.85 (m, 1H), 1.43-1.50 (m, 1H), 1.11 (d, J=7.4, 3H), 
0.99 (d, J=6.0, 3H), 0.92-0.99 (m, 2H) 0.92 (d, J=6.6, 3H), 0.88 (s, 9H), 0.01 (s, 6H). 
13C NMR (125 MHz, CDCl3) 178.8, 172.0, 137.1, 129.7, 128.5, 128.1, 127.6, 122.2, 96.6, 95.2, 80.5, 77.7, 
73.8, 73.2, 72.8, 68.2, 55.8, 46.4, 36.9, 34.6, 33.1, 32.0, 25.9, 25.2, 19.3, 18.3, 17.9, 15.8, -5.4. 
 
Minor diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.25-7.40 (m, 5H), 6.05-6.14 (m, 1H), 5.36-5.43 (m, 2H), 4.66 (d, J=11.6, 1H), 
4.62 (d, J=6.7, 1H), 4.57 (d, J=6.7, 1H), 4.42 (d, J=11.8, 1H), 4.29-4.31 (m, 1H), 4.20 (d, J=6.6, 1H), 4.01 
(dd, J1=3.6, J2=9.7, 1H), 3.54 (dd, J1=4.7, J2=9.8, 1H), 3.36 (s, 3H), 3.27 (dd, J1=7.2, J2=9.8, 1H), 2.72-2.80 
(m, 1H), 2.52-2.64 (m, 2H), 2.08-2.16 (m, 1H), 1.65-1.85 (m, 1H), 1.54-1.62 (m, 1H), 1.07 (d, J=7.2, 3H), 
0.92-0.99 (m, 2H), 0.92 (d, J=6.6, 3H), 0.91 (d, J=6.6, 3H), 0.89 (s, 9H), 0.05 (s, 6H). 
13C NMR (125 MHz, CDCl3) 179.4, 171.9, 137.1, 129.6, 128.5, 128.1, 127.6, 122.2, 96.0, 94.7, 80.5, 77.6, 
74.2, 73.4, 72.9, 67.9, 55.7, 46.4, 36.9, 34.6, 33.2, 32.1, 25.9, 25.87, 19.2, 18.6, 17.9, 16.5, -5.4. 
 
IR (film): cm-1 2957, 2930, 2884, 2856, 1755, 1684, 1459, 1100, 1036, 920. 
HRMS (m/z) [M+Na]+ calcd. for C34H52O7SiNa: 623.3374; found: 623.3345. 
Rf1,2=0.48 (petroleum ether : ethyl acetate =  4 : 1). 
 
2.47 (5R,6R,7aR,8R,9R)-6-benzyloxy-3-[(2R,4S)-5-(tert-butyldimethylsilyloxy)-1-
(methoxymethoxy)-2,4-dimethylpentyl]-6,7-dihydro-9-methyl-7-formyl-5H-5,7a-
ethano-2H-furo[3.2-b]pyran-2-one (66) 
 
 
Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry
This journal is © The Royal Society of Chemistry 2013
S45 
 
A stream of oxygen enriched with ozone was bubbled through the cold (‐78 °C) solution of alkene 65 
(124 mg; 0.2065 mmol) in dry dichloromethane (12 mL) for 12 minutes, when the reaction mixture 
turned light blue. The excess ozone was removed by bubbling argon gas, followed by the addition of 
dimethyl sulfide (0.2 mL). The mixture was stirred at room temperature for 5 h, when DBU (6.2 μL; 20 
mol%) was added and stirring was continued for 24 h. Another portion of DBU (3.1 μL; 10 mol%) was 
then added, and after additional 24 h of stirring the isomerization was complete (the progress of the 
reaction was followed by 1H NMR spectroscopy). The solvent was removed under reduced pressure and 
the residue purified by column chromatography (petroleum ether : ethyl acetete = 2 : 1) to give 100 mg 
(81%) of aldehyde 66 as a colorless oil. 
 
Spectral data for the mixture of diastereoisomers (assignation of peaks in 1H NMR and 13C NMR spectra 
is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer 
1H NMR (500 MHz, CDCl3) 9.60 (d, J=0.6, 1H), 7.26-7.38 (m, 5H), 4.46-4.57 (m, 4H), 4.34-4.40 (m, 2H), 
4.22 (d, J=5.3, 1H), 3.49 (dd, J1=4.6, J2=9.7, 1H), 3.34 (s, 3H), 3.26 (dd, J1=6.4, J2=9.7, 1H), 3.15 (d, J=4.0, 
1H), 2.72 (dd, J1=3.8, J2=11.5, 1H), 2.57-2.68 (m, 1H), 1.94-2.02 (m, 1H), 1.67-1.79 (m, 1H), 1.42 (ddd, 
J1=6.0, J2=7.2, J3=13.6, 1H), 1.15-1.21 (m, 1H), 1.12 (d, J=7.4, 3H), 0.96 (d, J=6.7, 3H), 0.91 (d, J=6.5, 3H), 
0.87-0.92 (m, 1H), 0.88 (s, 9H), 0.02 (s, 6H). 
13C NMR (125 MHz, CDCl3) 197.6, 175.3, 170.8, 136.7, 128.6, 128.4, 127.9, 98.4, 95.0, 79.6, 76.8, 73.2, 
72.3, 71.7, 68.2, 56.0, 55.9, 38.2, 36.8, 34.5, 33.0, 25.9, 25.5, 19.0, 18.3, 17.7, 15.7, -5.4. 
 
Minor diastereoisomer 
1H NMR (500 MHz, CDCl3) 9.60 (d, J=0.6, 1H), 7.26-7.38 (m, 5H), 4.46-4.57 (m, 4H), 4.34-4.40 (m, 2H), 
4.14 (d, J=7.0, 1H), 3.53 (dd, J1=4.7, J2=9.7, 1H), 3.35 (s, 3H), 3.27 (dd, J1=6.5, J2=9.7, 1H), 3.14 (d, J=4.0, 
1H), 2.75 (dd, J1=3.6, J2=11.2, 1H), 2.57-2.68 (m, 1H), 2.02-2.12 (m, 1H), 1.67-1.79 (m, 1H), 1.51 (ddd, 
J1=4.3, J2=8.6, J3=13.2, 1H), 1.15-1.21 (m, 1H), 1.08 (d, J=7.1, 3H), 0.92 (d, J=6.5, 3H), 0.87-0.92 (m, 1H), 
0.89 (s, 9H), 0.84 (d, J=6.8, 3H), 0.03 (s, 6H). 
13C NMR (125 MHz, CDCl3) 197.5, 176.0, 170.8, 136.7, 128.6, 128.4, 127.9, 97.7, 94.6, 79.6, 76.7, 73.9, 
72.3, 71.7, 67.9, 55.9, 55.8, 38.4, 37.1, 34.5, 33.1, 25.9, 25.6, 18.9, 18.5, 17.7, 16.0, -5.4. 
 
IR (film): cm-1 2955, 2930, 2884, 2856, 1761, 1725, 1682, 1250, 1091, 1034, 838. 
HRMS (m/z) [M+Na]+ calcd. for C33H50O8SiNa: 625.3167; found: 625.3151. 
Rf=0.32-0.44 (petroleum ether : ethyl acetate = 3 : 1). 
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2.48 (5R,6R,7aR,8R,9R)-6-benzyloxy-6,7-dihydro-7-(E-2-iodovinyl)-3-[(2R,4S)-5-(tert-
butyldimethylsilyloxy)-1-(methoxymethoxy)-2,4-dimethylpentyl]-9-methyl-5H-5,7a-
ethano-2H-furo-[3.2-b]pyran-2-one (67) 
 
 
Commercial chromium(II) chloride (340 mg; 2.77 mmol; 24 eq; 99.9% purity) was suspended in dry 
tetrahydrofuran (1.5 mL), in a glovebox, under an argon atmosphere. A solution of aldehyde 66 (67 mg; 
0.111 mmol) and iodoform (362 mg; 8 eq) in dry THF (4 mL + 2 x 1.5 mL to rinse) was added dropwise to 
the greenish suspension and the mixture was stirred for 10 minutes at room temperature, followed by 
additional 15 minutes at 50 °C. The reaction mixture was partitioned between ethyl acetate and brine, 
the organic layer was dried over MgSO4 and concentrated under reduced pressure. Purification of the 
residue by column chromatography (gradient elution: petroleum ether : ethyl acetate = 9 : 1 → 2 : 1), 
afforded 49 mg (61%) of the title compound 67 as a colorless oil, followed by 6.7 mg (10%) of the 
desilylated product 77. The overall yield in the Takai olefination was 71%. 
 
Spectral data for the mixture of diastereoisomers (assignation of peaks in 1H NMR and 13C NMR spectra 
is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.26-7.40 (m, 5H), 6.30 (dd, J1=0.7, J2=14.6, 1H), 6.10 (dd, J1=9.0, J2=14.6, 
1H), 4.51-4.64 (m, 4H), 4.32 (d, J=3.7, 1H), 4.24 (d, J=5.7, 1H), 3.71 (t, J=3.8, 1H), 3.52 (dd, J1=5.4, J2=9.8, 
1H), 3.35 (s, 3H), 3.24-3.31 (m, 1H), 2.76-2.81 (m, 1H), 2.54-2.65 (m, 2H), 1.98-2.19 (m, 1H), 1.68-1.84 
(m, 1H), 1.38-1.47 (m, 1H), 1.13-1.20 (m, 1H), 1.11 (d, J=6.8, 3H), 0.99 (d, J=6.5, 3H), 0.92 (d, J=6.8, 3H), 
0.88 (s, 9H), 0.02 (s, 6H). 
13C NMR (125 MHz, CDCl3) 175.3, 171.5, 140.2, 136.7, 128.7, 128.4, 127.8, 99.0, 95.7, 80.9, 79.7, 77.4, 
76.3, 74.2, 72.1, 68.2, 55.9, 51.9, 37.5, 37.0, 34.5, 33.0, 25.9, 25.3, 19.0, 18.3, 18.0, 15.9, -5.4. 
 
Minor diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.26-7.40 (m, 5H), 6.30 (dd, J1=0.9, J2=14.6), 6.13 (dd, J1=8.9, J2=14.7, 1H), 
4.51-4.64 (m, 4H), 4.32 (d, J=3.7, 1H), 4.18 (d, J=7.3, 1H), 3.82 (t, J=3.8, 1H), 3.57 (dd, J1=4.9, J2=10.0, 1H), 
3.37 (s, 3H), 3.24-3.31 (m, 1H), 2.76-2.81 (m, 1H), 2.54-2.65 (m, 2H), 1.98-2.19 (m, 1H), 1.68-1.84 (m, 
1H), 1.54-1.61 (m, 1H), 1.13-1.20 (m, 1H), 1.06 (d, J=6.8, 3H), 0.92 (d, J=6.8, 3H), 0.89 (s, 9H) 0.88 (d, 
J=5.9, 3H), 0.039 (s, 3H), 0.036 (s, 3H). 
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13C NMR (125 MHz, CDCl3) 175.8, 171.4, 140.3, 136.8, 128.7, 127.84, 127.81, 98.1, 94.7, 81.0, 79.7, 
77.4, 76.2, 74.2, 72.1, 68.0, 55.8, 51.7, 37.6, 37.0, 34.9, 33.1, 25.9, 25.4, 18.9, 18.6, 18.3, 16.2, -5.3. 
 
IR (film): cm-1 2955, 2930, 2883, 2857, 1756, 1682, 1492, 1090, 1035. 
HRMS (m/z) [M+Na]+ calcd. for C34H51O7ISiNa: 749.2341; found: 749.2349. 
Rf1=0.43, Rf2=0.50 (petroleum ether : ethyl acetate = 4 : 1). 
 
2.49  (5R,6R,7aR,8R,9R)-6-benzyloxy-6,7-dihydro-7-(E-2-iodovinyl)-3-[(2R,4S)-1-
(methoxymethoxy)-2,4-dimethyl-5-oxopentyl]-9-methyl-5H-5,7a-ethano-2H-furo-[3.2-
b]pyran-2-one (68) 
 
A) Compound 77 (deprotection of 67): A solution of 67 (62 mg; 0.085 mmol) and 1M hydrochloric acid 
(40 μL) in methanol (5 mL) was stirred at room temperature for 1 h. The solution was evaporated to 
dryness and filtered through a short pad of silica (eluent: petroleum ether : ethyl acetate = 1 : 1), to yield 
48.6 mg (94%) of the alcohol 77, as a colorless oil. 
 
Spectral data for the mixture of diastereoisomers 77 (assignation of peaks in 1H NMR and 13C NMR 
spectra is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.26-7.40 (m, 5H), 6.31 (dd, J1=0.7, J2=14.4, 1H), 6.10 (dd, J1=9.1, J2=14.5, 
1H), 4.51-4.63 (m, 4H), 4.33 (d, J=3.2, 1H), 4.20 (d, J=6.8, 1H), 3.72 (t, J=4.0, 1H), 3.48-3.55 (m, 1H), 3.42-
3.48 (m, 1H), 3.36 (s, 3H), 2.76-2.81 (m, 1H), 2.55-2.66 (m, 2H), 2.04-2.18 (m, 1H), 1.74-1.83 (m, 1H), 
1.65-1.74 (bs, 1H), 1.58-1.65 (m, 1H), 1.41-1.49 (m, 1H), 1.13-1.21 (m, 1H), 1.11 (d, J=6.7, 3H), 1.01 (d, 
J=6.8, 3H), 0.98 (d, J=6.7, 3H). 
13C NMR (125 MHz, CDCl3) 175.9, 171.6, 140.1, 136.7, 128.7, 128.4, 127.8, 98.6, 95.9, 81.0, 79.8, 77.4, 
76.3, 74.1, 72.1, 67.4, 56.0, 51.8, 37.4, 36.6, 34.2, 32.9, 25.3, 19.0, 18.1, 16.2. 
 
Minor diastereoisomer 
1H NMR (500 MHz, CDCl3) 7.26-7.40 (m, 5H), 6.31 (dd, J1=0.7, J2=14.5, 1H), 6.15 (dd, J1=8.8, J2=14.5, 
1H), 4.51-4.63 (m, 4H), 4.33 (d, J=3.2, 1H), 4.25 (d, J=6.6, 1H), 3.77 (t, J=3.9, 1H), 3.48-3.55 (m, 1H), 3.42-
3.48 (m, 1H), 3.38 (s, 3H), 2.76-2.81 (m, 1H), 2.55-2.66 (m, 2H), 2.04-2.18 (m, 1H), 1.74-1.83 (m, 1H), 
1.65-1.74 (bs), 1.58-1.65 (m, 1H), 1.41-1.49 (m, 1H), 1.13-1.21 (m, 1H), 1.06 (d, J=6.7, 3H), 0.98 (d, J=6.9, 
3H), 0.92 (d, J=6.9, 3H). 
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13C NMR (125 MHz, CDCl3) 176.0, 171.6, 140.2, 136.7, 128.7, 128.4, 127.8, 97.9, 94.7, 81.1, 79.7, 77.4, 
76.3, 74.1, 72.0, 67.3, 55.9, 51.6, 37.6, 36.6, 34.9, 33.3, 25.3, 19.0, 18.2, 16.8. 

IR (film): cm-1 3489, 2959, 2929, 2878, 1754, 1680, 1456, 1409, 1075, 1033, 915. 
HRMS (m/z) [M+Na]+ calcd. for C28H37O7ISiNa: 635.1476; found: 635.1468. 
Rf1=0.56, Rf2=0.65 (petroleum ether : ethyl acetate = 1 : 1). 
 
B) Compound 68 (oxidation of 77): Dess Martin’s periodinane (76 mg; 0.180 mmol; 2 eq) was added to 
the solution of alcohol 77 (55 mg; 0.09 mmol) in dry dichloromethane (5 mL), and the resulting 
suspension was stirred at room temperature for 15 minutes. The reaction mixture was diluted with ethyl 
acetate and water, the organic layer was washed successively with 5% sodium thiosulfate, sodium 
bicarbonate and brine, dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Purification of the residue by column chromatography (eluent: petroleum ether : ethyl acetate = 2 : 1) 
afforded 48 mg (88%) of the title aldehyde 68 as a colorless oil. 
 
Spectral data for the mixture of diastereoisomers (assignation of peaks in 1H NMR and 13C NMR spectra 
is based on the detailed analysis of COSY, HSQC, HMBC and NOESY NMR spectra of the mixture): 
 
Major diastereoisomer 
1H NMR (500 MHz, CDCl3) 9.59 (d, J=2.5, 1H), 7.26-7.40 (m, 5H), 6.31 (dd, J1=0.8, J2=14.6, 1H), 6.10 (dd, 
J1=8.9, J2=14.6, 1H), 4.52-4.64 (m, 4H), 4.35 (d, J=3.7, 1H), 4.25 (d, J=6.1, 1H), 3.73 (t, J=3.9, 1H), 3.35 (s, 
3H), 2.77-2.83 (m, 1H), 2.48-2.68 (m, 3H), 2.01-2.12 (m, 2H), 1.85-1.92 (m, 1H), 1.15-1.22 (m, 2H), 1.13 
(d, J=7.1, 6H), 0.99 (d, J=6.8, 3H). 
13C NMR (125 MHz, CDCl3) 204.8, 175.8, 171.5, 140.1, 136.7, 128.6, 128.4, 127.8, 98.3, 95.5, 81.0, 79.9, 
77.2, 76.4, 73.6, 72.0, 56.0, 51.7, 43.8, 37.4, 34.5, 33.8, 25.3, 19.0, 15.7, 14.2. 
 
Minor diastereoisomer 
1H NMR (500 MHz, CDCl3) 9.59 (d, J=2.5, 1H), 7.26-7.40 (m, 5H), 6.30 (dd, J1=0.8, J2=14.6, 1H), 6.14 (dd, 
J1=8.6, J2=14.6, 1H), 4.52-4.64 (m, 4H), 4.35 (d, J=3.7, 1H), 4.24 (d, J=6.8, 1H), 3.79 (t, J=3.8, 1H), 3.38 (s, 
3H), 2.77-2.83 (m, 1H), 2.48-2.68 (m, 3H), 2.01-2.12 (m, 2H), 1.15-1.22 (m, 2H), 1.11 (d, J=7.0, 3H), 1.06 
(d, J=6.5, 3H), 0.90 (d, J=6.5, 3H). 
13C NMR (125 MHz, CDCl3) 205.1, 176.1, 171.5, 140.2, 136.6, 128.6, 127.83, 127.81, 97.7, 94.6, 81.0, 
79.8, 77.2, 76.4, 73.7, 72.1, 55.9, 51.5, 44.1, 37.5, 34.9, 34.3, 25.3, 18.9, 16.1, 14.5. 
 
IR (film): cm-1 2960, 2923, 2877, 1755, 1721, 1680, 1456, 1409, 1075, 1031, 914. 
HRMS (m/z) [M+NH4]
+ calcd. for C28H39O7NISi: 628.1766; found: 628.1763. 
Rf1=0.52, Rf2=0.58 (petroleum ether : ethyl acetate = 2 : 1). 
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2.50 (5R,7S,9E,10aR,11R,12R,13R,14aR)-11-(benzyloxy)-5,6,7,8,11,12,13,14-octahydro-8-
hydroxy-4-(methoxymethoxy)-5,7,13-trimethyl-12,14a,3-(epoxymethyno)-2H-1-
benzoxacyclododecin-2-2(4H,10aH)-one (69) 
 
 
Commercial chromium(II) chloride (167 mg; 1.36 mmol; 17 eq; 99.9% purity) and anhydrous nickel(II) 
chloride (cat. amount) were suspended in a freshly distilled dry DMF (3 mL), in a glovebox, under an 
argon atmosphere. The solution of 68 (48 mg; 0.0786 mmol) in DMF (11 mL) was added dropwise to the 
suspension, and the mixture was stirred at room temperature for 90 minutes. After additional stirring at 
45 °C for 15 minutes, the mixture was partitioned between diethyl ether and diluted hydrochloric acid 
(1M). The etheral layer was washed with diluted hydrochloric acid (1 M), brine, dried over MgSO4 and 
concentrated under reduced pressure. Purification of the residue by column chromatography (gradient 
elution: petroleum ether : ethyl acetate = 3 : 1 → 1 : 1) afforded 34 mg (90%) of the title compound 69 
as a mixture of four diastereoisomers. Additionally, 3.4 mg of the unreacted starting material was 
isolated; therefore, the yield based on the recovered starting material was 96%. 
 
IR (film): cm-1 3479, 2955, 2929, 2873, 1751, 1680, 1092, 1025. 
HRMS (m/z) [M+Na]+ calcd. for C28H36NaO7: 507.2353; found: 507.2352. 
Rf1=0.61, Rf2=0.71 (petroleum ether : ethyl acetate = 1 : 1). 
2.51  (5R,7S,9E,10aR,11R,12R,13R,14aR)-11-(benzyloxy)-6,7,11,12,13,14-hexahydro-5,7,13-
trimethyl-12,14a,3-(epoxymethyno)-2H-1-benzoxacyclododecin-2,4,8(5H,10aH)-trione 
(70) and (3S,5R,7S,9E,10aR,11R,12R,13R,14aR)-4-chloro-11-(benzyloxy)-6,7,11,12,13,14-
hexahydro-5,7,13-trimethyl-12,14a,3-(epoxymethyno)-2H-1-benzoxacyclododecin-
2,8(5H,10aH)-dione (71) 
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A solution of compound 69 (3.5 mg; 7.22 μmol) and concentrated hydrochloric acid (15 μL) in methanol 
(0.2 mL) was stirred at room temperature for 4 days and then evaporated under reduced pressure. The 
residue was dissolved in dry dichloromethane (0.8 mL) and Dess Martin’s periodinane (30.6 mg; 0.722 
μmol; 10 eq) was added. The mixture was stirred for 3 h at room temperature, then partitioned 
between diethyl ether and water. The organic layer was washed with 10% sodium thiosulfate, sodium 
bicarbonate and brine, dried over MgSO4 and concentrated under reduced pressure. Purification of the 
residue by column chromatography (eluent: petroleum ether : ethyl acetate = 3 : 1) afforded 0.5 mg 
(14%) of chloro-derivative 71, followed by 2.4 mg (78%) of the compound 70, as colorless oils. 
 
Spectral data for compound 70 
1H NMR (500 MHz, CDCl3) 7.24-7.38 (m, 5H), 6.70 (dd, J1= 5.9, J2=16.4, 1H), 6.15 (d, J=16.4, 1H), 4.61 
(d, J=11.3, 1H), 4.56 (dd, J1=1.5, J2=4.2, 1H), 4.43 (d, J=11.3, 1H), 4.01 (dd, 
J1=3.0, J2=4.1, 1H), 3.21 (ddd, J1=0.8, J2=2.9, J3=6.0, 1H), 2.71-2.82 (m, 2H), 
2.67 (dd, J1=1.2, J2=11.2, 1H), 2.58-2.66 (m, 1H), 1.75 (ddd, J1=3.1, J2=11.4, 
J3=15.9, 1H), 1.51 (dd, J1=3.0, J2=12.5, 1H), 1.46 (ddd, J1=4.0, J2=4.6, J3=15.9, 
1H), 1.16-1.19 (m, 6H), 1.11 (d, J=7.1, 3H). 
13C NMR (125 MHz, CDCl3) 201.5, 199.3, 177.5, 169.0, 138.1, 136.2, 128.7, 
128.6, 128.5, 128.0, 106.5, 81.3, 79.5, 73.6, 71.9, 47.9, 47.6, 42.9, 38.7, 33.4, 
25.5, 18.6, 18.1, 17.2. 
IR (film): cm-1 2965, 2929, 2873, 1759, 1693, 1647, 1456, 1088, 960. 
HRMS (m/z) [M+K]+ calcd. for C26H28KO6: 475.1517; found: 475.1517. 
[]D
20 -81.8 (c 0.5, CHCl3). 
Rf=0.40 (petroleum ether : ethyl acetate = 2 : 1). 
 
Spectral data for chloro-derivative 71 
1H NMR (500 MHz, CDCl3) 7.27-7.40 (m, 5H), 6.38 (dd, J1=4.1, J2=17.0, 1H), 
6.16 (dd, J1=1.3, J2=17.0, 1H), 4.64 (d, J=11.9, 1H), 4.50 (dd, J1=1.7, J2=4.5, 1H), 
4.46 (d, J=11.9, 1H), 4.23 (d, J=11.1, 1H), 4.14 (dd, J1=2.1, J2=4.5, 1H), 3.07-3.10 
(m, 1H), 2.70-2.78 (m, 2H), 2.66 (dd, J1=11.0, J2=12.4, 1H), 2.50-2.58 (m, 1H), 
1.98-2.09 (m, 1H), 1.40-1.47 (m, 2H), 1.18 (d, J=6.7, 3H), 1.12 (d, J=7.2, 3H), 
1.09-1.19 (m, 1H), 1.09 (d, J=6.8, 3H). 
13C NMR (125 MHz, CDCl3) 2-03.5, 173.1, 169.6, 137.3, 136.5, 130.4, 128.7, 
128.5, 127.8, 101.0, 80.7, 78.6, 72.3, 71.7, 55.8, 47.8, 46.1, 40.7, 38.1, 34.3, 
25.5, 21.5, 18.5, 16.1.
IR (film): cm-1 2926, 1764, 1682, 1455, 1406, 1068. 
HRMS (m/z) [M+Na]+ calcd. for C26H29ClO5Na: 479.1596; found: 479.1598. 
[]D
20 -37.0 (c 0.1, CHCl3). 
Rf= 0.41 (petroleum ether : ethyl acetate = 3 : 1). 
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2.52 Abyssomicin H 
 
A suspension of compound 70 (1.35 mg; 3.09 μmol) and palladium on carbon (1 mg, 5% Pd/C) in ethyl 
acetate (500 μL) was vigorously stirred overnight under a hydrogen atmosphere (4 atm). The catalyst 
was removed by filtration through a short pad of celite, and the solvent was removed under reduced 
pressure. Purification by dry‐flash chromatography (eluent: petroleum ether : ethyl acetete = 2 : 3) 
afforded abyssomicin H (0.8 mg, 74%), as a white amorphous solid. 
 
1H NMR (500 MHz, MeOD-d4)  4.55 (dd, J1=1.1, J2=3.8, 1H), 4.46 (dd, J1=3.8, J2=5.2, 1H), 3.31-3.37 (m, 
1H), 2.78 (ddd, J1=3.3, J2=11.1, J3=18.8, 1H), 2.73 (ddd, J1=2.1, J2=7.2, J3=10.7, 1H), 2.63-2.70 (m, 2H), 
2.60 (dd, J1=11.1, J2=12.0, 1H), 2.22-2.26 (m, 1H), 2.14-2.22 (m, 1H), 1.89-1.99 (m, 2H) 1.44 (ddd, J1=2.1, 
J2=3.0, J3=14.6, 1H), 1.13 (dd, J1=4.2, J2=12.0, 1H), 1.11 (d, J=7.1, 3H), 1.08 (d, J=6.8, 3H), 1.05 (d, J=7.2, 
3H). 1H NMR spectrum for this compound has been reported, with chemical shifts identical to these 
presented in this manuscript.10 However, as no coupling constants were listed in the literature report, 
we provide the full listing of the 1H NMR spectrum here. 
Rf=0.24 (petroleum ether : ethyl acetate = 1 : 1). 
 
2.53 atrop-Abyssomicin C (AA) 
 
 
A solution of boron(III) bromide (15 μL; 0.155 mmol; 15 eq) in dry dichloromethane (300 μL) was added 
dropwise to a cold (0 °C) solution of compound 70 (4.5 mg; 10.3 μmol) in dry dichloromethane (2 mL), 
under an argon atmosphere. The reaction mixture was stirred at room temperature for one hour and 
then partitioned between diethyl ether and saturated sodium bicarbonate solution. The organic layer 
was washed with brine, dried over anhydrous MgSO4 and concentrated under reduced pressure. 
Purification of the residue by column chromatography (gradient elution: petroleum ether : ethyl acetate 
= 7 : 3 → 1 : 2) afforded 2.9 mg (81%) of atrop-abyssomicin C (2.9 mg; 81%), as a white amorphous solid. 
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1H NMR (500 MHz, MeOD-d4) 6.65 (dd, J1=5.8, J2=16.5, 1H), 6.52 (d, J=16.5, 1H), 4.63 (dd, J1=1.4, 
J2=4.3, 1H), 4.41 (dd, J1=3.1, J2=4.3, 1H), 3.19 (ddd, J1=0.7, J2=2.9, J3=5.7, 1H), 2.78-2.83 (m, 1H), 2.70 (dd, 
J1=10.7, J2=12.6, 1H), 2.62-2.66 (m, 1H), 2.54 (ddq, J1=3.6, J2=7.1, J3=14.3, 1H), 1.88 (ddd, J1=2.5, J2=12.2, 
J3=15.7, 1H), 1.43-1.48 (m, 2H), 1.16 (d, J=7.0, 3H), 1.15 (d, J=7.0, 3H), 1.12 (d, J=6.7, 3H). 
13C NMR (125 MHz, MeOD-d4) 204.3, 201.3, 180.2, 171.6, 141.0, 129.8, 107.0, 85.2, 81.9, 67.7, 51.3, 
49.8, 44.3, 39.4, 34.5, 26.4, 18.9, 18.2, 17.1. 
HRMS (m/z) [M+NH4]
+ calcd. for C19H26NO6: 364.1755; found: 364.1754. 
[]D
20 -72.7 (c 0.17, MeOH).11 
Rf=0.32 (petroleum ether : ethyl acetate = 1 : 2). 
 
2.54 (4S,5R,7S,9E,10aR,11R,12R,13R,14aR)-11-(benzyloxy)-5,6,7,11,12,13,14-pentahydro-4-
(methoxymethoxy)-5,7,13-trimethyl-12,14a,3-(epoxymethyno)-2H-1-
benzoxacyclododecin-2,8(5H,10aH)-dione (72) and 
(4R,5R,7S,9E,10aR,11R,12R,13R,14aR)-11-(benzyloxy)-5,6,7,11,12,13,14-pentahydro-4-
(methoxymethoxy)-5,7,13-trimethyl-12,14a,3-(epoxymethyno)-2H-1-
benzoxacyclododecin-2,8(5H,10aH)-dione (73) 
 
Freshly prepared DMP (9.2 mg; 21.7 mol; 3 eq) was added to a solution of 69 (3.5 mg; 7.2 mol) in dry 
dichloromethane (350 L) and the resulted suspension was stirred for 60 minutes at room temperature. 
The reaction mixture was partitioned between diethyl ether and 10% sodium thiosulfate solution and 
the organic extract was washed with saturated sodium bicarbonate solution and brine, dried over 
anhydrous MgSO4 and concentrated under reduced pressure. Purification of the residue by preparative 
HPLC afforded 1.7 mg (49%) of 72 and 1.2 mg (34%) of 73, as colorless oils. 
 
Spectral data for derivative 72 
 
1H NMR (500 MHz, CDCl3)  7.26-7.38 (m, 5H), 6.56 (dd, J1=1, J2=17, 1H), 6.46 (d, J=17, 1H), 4.66 (d, 
J=6.5, 1H), 4.62 (d, J=12, 1H), 4.60 (d, J=6.5, 1H), 4.48 (dd, J1=3.5, J2=4.5, 1H), 4.43 (d, J=12, 1H), 4.30 (s, 
1H), 4.19 (dd, J1=1.5, J2=4.5, 1H), 3.39 (s, 3H), 3.10 (dd, J1=2, J2=5, 1H), 2.62-2.73 (m, 2H), 2.36-2.44 (m, 
1H), 1.99 (dd, J1=12.5, J2=15, 1H), 1.36 (dd, J1=1.5, J2=12, 1H), 1.29-1.32 (m, 1H), 1.19 (dd, J1=2.5, J2=8, 
1H), 1.15 (d, J=7, 3H), 1.11 (d, J=6.5, 3H), 1.07 (d, J=7, 3H). 
13C NMR (125 MHz, CDCl3)  203.1, 172.4, 171.2, 137.8, 136.5, 129.6, 128.6, 128.4, 127.9, 101.5, 94.8, 
79.9, 79.4, 75.8, 72.7, 71.6, 55.8, 47.9, 46.8, 37.4, 36.0, 34.8, 25.3, 19.9, 18.4, 18.2. 
IR (film): cm-1 2958, 2926, 1750, 1685, 1456, 1033, 913. 
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HRMS (m/z) [M+H]+ calcd. for C28H35O7: 483.2377; found: 483.2378. 
[]D
20 +7.0 (c 0.1, CHCl3). 
Rf=0.48 (petroleum ether : ethyl acetate = 2 : 1). 
 
 
Spectral data for derivative 73 
 
1H NMR (500 MHz, CDCl3)  7.28-7.40 (m, 5H), 6.42 (dd, J1=4, J2=17, 1H), 6.21 (dd, J1=1, J2=17, 1H), 4.63 
(d, J=11.5, 1H), 4.59 (d, J=7, 1H), 4.56 (d, J=7, 1H), 4.49 (dd, J1=1.5, J2=4.5, 1H), 4.46 (d, J=11.5, 1H), 4.16 
(dd, J1=1.5, J2=4.5, 1H), 3.88 (d, J=10.5, 1H), 3.34 (s, 3H), 3.08-3.09 (m, 1H), 2.65-2.72 (m, 2H), 2.49-2.56 
(m, 1H), 1.86-1.91 (m, 1H), 1.42 (ddd, J1=2.5, J2=7.5, J3=15, 1H), 1.37 (dd, J1=1, J2=11.5, 1H), 1.10 (d, 
J=6.5, 9H), 1.04 (dt, J1=5.5, J2=15, 1H). 
13C NMR (125 MHz, CDCl3)  203.8, 175.6. 170.4, 137.4, 136.6, 130.3, 128.7, 128.4, 127.8, 100.0, 94.9, 
80.2, 78.6, 72.5, 72.4, 71.6, 55.7, 47.8, 46.1, 39.4, 36.4, 34.9, 25.6, 19.6, 18.5, 16.5. 
IR (film): cm-1 2929, 2874, 1766, 1683, 1455, 1407, 1095, 1025, 734. 
HRMS (m/z) [M+H]+ calcd. for C28H34O7: 483.2377; found: 483.2365. 
[]D
20 -65.0 (c 0.1, CHCl3). 
Rf=0.35 (petroleum ether : ethyl acetate = 2 : 1). 
 
2.55 (3S,5R,7S,9E,10aR,11R,12R,13R,14aR)-4-chloro-11-(benzyloxy)-6,7,9,10,11,12,13,14-
octahydro-5,7,13-trimethyl-10-(phenylthio)-12,14a,3-(epoxymethyno)-2H-1-
benzoxacyclododecin-2,8(5H,10aH)-dione (74)  (addition of thiophenol to chloro-
derivative 71) 
 
A mixture of chloro-derivative 71 (1.1 mg; 2.41 mol), thiophenol (0.5 L; 4.82 mol; 2 eq) and 
triethylamine (0.65 L; 4.82 mol; 2 eq) in dry THF (1 mL) was stirred for 2 h at room temperature, 
under an argon atmosphere. All volatiles were evaporated on rotovap and the mixture was purified by 
HPLC to give two isomers of products 74 (diastereoisomer 1: 0.34 mg; 25% and diastereoisomer 2: 0.29 
mg; 22%).  
 
Spectral data for diastereoisomer 1 
1H NMR (500 MHz, CDCl3)  7.25-7.41 (m, 10H), 4.88 (d, J=11.4, 1H), 4.67 (d, J=11.4, 1H), 4.39 (dd, J1=1.5, 
J2=4.1, 1H), 4.27 (d, J=11.7, 1H), 4.16-4.20 (m, 1H), 4.01 (t, J=3.8, 1H), 2.77 (dd, J1=4.7, J2=18.1, 1H), 2.58-
2.69 (m, 1H), 2.55 (dd, J1=2.2, J2=3.4, 1H), 2.42-2.52 (m, 2H), 2.30-2.38 (m, 1H), 2.23 (dd, J1=4.8, J2=18.1, 
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1H), 1.27-1.37 (m, 2H), 1.19 (d, J=6.8, 3H), 1.10 (dd, J1=3.5, J2=12.7, 1H), 1.02 (d, J=7.3, 3H), 0.99 (d, 
J=6.8, 3H), 0.88-0.92 (m, 2H). 
13C NMR (125 MHz, CDCl3)  207.1, 174.3, 169.3, 137.3, 133.4, 131.6, 129.2, 128.6, 128.3, 128.0, 127.6, 
99.0, 80.7, 74.5, 72.5, 56.0, 49.1, 46.5, 41.0, 38.7, 38.4, 36.9, 36.7, 29.7, 25.7, 22.1, 18.7, 17.7. 
HRMS (m/z) [M+H]+ calcd. for C32H36ClO5Si: 567.1966; found: 567.1977. 
Rf=0.44 (petroleum ether : ethyl acetate = 3 : 1). 
 
Spectral data for diastereoisomer 2 
1H NMR (500 MHz, CDCl3)  7.51-7.55 (m, 2H), 7.31-7.41 (m, 8H), 4.80 (d, J=11.3, 1H), 4.58 (d, J=11.3, 
1H), 4.41 (dd, J1=1.2, J2=4.1, 1H), 4.11 (d, J=11.2, 1H), 4.00 (t, J=3.7, 1H), 3.74-3.77 (m, 1H), 2.86 (dd, 
J1=2.6, J2=3.7, 1H), 2.73 (dd, J1=4.7, J2=18.0, 1H), 2.64-2.71 (m, 1H), 2.60 (t, J=11.9, 1H), 2.40-2.46 (m, 
1H), 2.27-2.33 (m, 2H), 1.26-1.39 (m, 4H), 1.17 (d, J=6.9, 3H), 1.14-1.18 (m, 1H), 1.04 (d, J=7.2, 3H), 0.96 
(d, J=6.9, 3H). 
13C NMR (125 MHz, CDCl3)  207.0, 174.2, 169.2, 137.1, 135.8, 129.3, 129.1, 128.7, 128.3, 128.1, 127.9, 
99.0, 80.6, 74.3, 72.6, 56.0, 48.9, 46.3, 40.9, 39.8, 38.3, 36.7, 31.9, 29.4, 25.7, 22.7, 18.7, 17.7. 
HRMS (m/z) [M+H]+ calcd. for C32H36ClO5Si: 567.1966; found: 567.1975. 
Rf=0.42 (petroleum ether : ethyl acetate = 3 : 1). 
 
3 Biological test 
3.1. Antibacterial activity 
The agar plate diffusion assay, and the determination of MIC values were performed according to the 
literature procedure.12 The determination of MIC was modified, with respect to the literature procedure, 
in that Mueller Hinton broth was used. 
3.2. Cytotoxicity assay 
Reagents: RPMI-1640 medium was purchased from PAA The Cell Culture Company (Linz, Austria), Fetal 
calf serum (FCS), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), gentamicin 
sulfate salt, penicillin, streptomycin, glutamine, β-mercaptoethanol,  phytohemagglutinin (PHA),  
dimethyl sulfoxide (DMSO) and Histopaque were purchased from the Sigma Chemical Co. (St. Louis, MO, 
USA), 0.22 μm Millipore Ultrafree-MC centrifugal devices were purchased from Merck Millipore 
(Billerica, Massachusetts, US). 
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Cell culture. Human cervix adenocarcinoma cells (HeLa), were grown in RPMI-1640 medium 
supplemented with 10% fetal calf serum (FCS), 1% glutamine (200 mM), 1% penicillin (10000 IU mL-1) 
and 1% streptomycin (10 mg mL-1). The cells were grown at 37 °C in a 6.0 % CO2 humidified air 
atmosphere. Peripheral blood mononuclear cells (PBMC) were separated from whole heparinized blood 
of healthy volunteer. Blood was diluted with phosphate buffered saline (PBS) (1:1) and layered on 
Histopaque solution. After centrifugation, interface cells were collected and washed three times with 
PBS. After counting, cells were resuspended in nutrient medium. Nutrient medium was RPMI-1640 
medium, supplemented with 10% fetal calf serum (FCS), 1% glutamine (200 mM), 1% β-
mercaptoethanol (5 µM), 1% penicillin (10000 IU mL-1), 1% streptomycin (10 mg mL-1) and with 0,5% 
phytohemagglutinin (PHA) (1 mg mL-1). The cells were grown at 37°C in a humidified atmosphere with 
6% CO2. 
Determination of target cell survival. HeLa cells were seeded (10 000 cells per well) into 96-well 
microtiter plates and 24 h later, after the cell adherence, six different concentrations of investigated 
compounds were added to the wells. Final concentrations were in the range from 0,0144 nM to 144 nM 
for HeLa cells and PBMCs. Only nutrient medium was added to the cells in the control wells. All 
experiments were done in triplicate. Nutrient medium void of cells was used as blank. PBMC were 
seeded (200,000 cells per well) into nutrient medium in 96-well microtiter plates and 2 h later, 
investigated compounds were added to the wells, in triplicates, to six final concentrations, except to the 
control wells where a nutrient medium only was added to the cells. Nutrient medium void of cells was 
used as blank. Cell survival was determined by MTT test according to the method of Mosmann13 and 
modified by Ohno and Abe,14 24 and 72 h after the drug addition to HeLa cells and PBMCs, respectively. 
Briefly, 20 µL of MTT solution (5 mg/mL in PBS) were added to each well and incubated for 4 h at 37 °C 
in humidified atmosphere with 6% CO2. After the incubation, medium was carefully removed and 200 μL 
of DMSO were added to dissolve the formazan complexes; absorbance was read at 492 nm. The IC50 
value which represents drug concentration that diminishes 50% of viable cells was assessed from the 
graph of cell survival vs. concentration of the investigated compound. 
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Results of the determination of cytotoxicity of compounds AA, 
70, 71, 72 and 73 on HeLa cells 
 
 
 
 
Compound: AA (atrop-abyssomicin C) IC50  = 31.77 nM; IC90 = 68.32 nM 
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Compound: 70  IC50  = 18.38 nM; IC90 = 45.51 nM 
 
 
 
Compound: 71 IC50  = 18.45 nM; IC90 = 40.14 nM 
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Compound: 72 IC50  = 18.39 nM; IC90 = 50.73 nM 
 
 
 
 
Compound: 73 IC50  = 10.7 nM; IC90 = 80.52 nM 
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Results of the determination of cytotoxicity of compounds AA, 
70, 71, 72 and 73 on Peripheral blood mononuclear cells 
(PBMC) 
 
 
 
 
 
 
Compound: AA (atrop-abyssomicin C) IC50  = 7.48 nM; IC90 = 22.97 nM 
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Compound: 70  IC50  = 6.21 nM; IC90 = 15.07 nM 
 
 
 
Compound: 71  IC50  = 6.16 nM; IC90 = 17.42 nM 
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Compound: 72  IC50  = 5.07 nM; IC90 = 28.06 nM 
 
 
 
 
Compound: 70  IC50  = 5.01 nM; IC90 = 13.50 nM 
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5. Copies of spectra 
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